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There is a convergence between the needs of the medical community and the capabilities of the 
engineering community. For example, the scale of biomedical devices and sensors allow for finer, 
more cost-effective quantification of biological and chemical targets. By using micro-fabrication 
techniques, we design and demonstrate a variety of microfluidic sensors and actuators that allow 
us to interact with a biochemical environment. We demonstrate the performance of microfluidic 
blood-filtrations chips, immune-diagnostic assays, and evaporative coolers. Furthermore, we 
show how micro-fabricated platinum filaments can be used for highly localized heating and 
temperature measurement. We demonstrate that these filaments can be used as miniature IR 
spectroscopic sources. Finally, we describe and demonstrate novel combinatorial coding methods 
for increasing the information extracted from biochemical reactions. We show proof-principle of 
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C h a p t e r  1  
INTRODUCTION 
The quantification and characterization of bioanalytes in various serums can provide insight into 
the identification and quantification of pathogens. The capture and recognition of proteins, 
nucleic acids, and other biochemicals that are specific to certain illnesses, can be used to track the 
progression of these diseases. For example, measurements on protein markers for disease are 
routinely performed at medical facilities on a variety of patient samples such as blood serum, 
cerebro-spinal fluid, and urine. Protein markers are captured in vitro by utilizing the highly 
specific interactions between antibodies and their antigens; once captured, the presence of a 
particular antigen is determined by observing a reporting tag. In the case of antibody tests, these 
are usually fluorescent labels; one then correlates the intensity of the fluorescent signal with the 
quantity of antigen (e.g. protein) present. 
However, for a bioanalyte assay to reliably track fluctuations in pathogen concentrations, it must 
be sufficiently specific (to minimize false positives) and sufficiently sensitive (to minimize false 
negatives). By shrinking chemical chambers from the millimeter size-scale, as used currently in 
laboratories, to the micrometer size-scale, more sensitive measurements of bioanalytes can be 
made in extremely small sample volumes, in a highly parallelized fashion [1-4]. Using 
microfabrication techniques, borrowed from the semiconductor industry, we have made 
microfluidic valves, gates and mixers in elastomers such as polydimethylsiloxane (PDMS). This 
fabrication strategy has been investigated in detail by many others, and has resulted in a codified, 
repeatable method of manufacturing microfluidic devices [5-6]. 
These devices have been used to create automated chemical laboratories [7-9]. At the micro-liter 
and nano-liter size scale, low Reynolds number flows allow for interesting fluidics. For example, 
viscous forces are much greater than inertial forces in microfluidic geometries; this allows for 
laminar, rather than turbulent flows [10]. Laminar flows are conducive to diffusion-limited 
mixing, which is a feature that is readily exploited in many microfluidic devices [11]. 
In this thesis, we exploit diffusion-limited mixing by designing microfluidic reaction chambers 




with a chemical environment. We demonstrate that such interaction facilitates immuno-capture 
of antigens with high sensitivity. We show the efficacy of a microfluidic chip that performs an 
enzyme-linked immunosorbent assay (ELISA) to capture protein targets specific to multiple-
sclerosis symptom activity. As proof-of-principle that our portable, microfluidic platform is 
suited for qualitative protein detection, we capture and detected matrix metalloproteinase-9 
(MMP-9) and galactocerebroside (GalC) in concentrations down to 65 nM. In addition, we 
demonstrate how similar passive elastomeric structures can be used for preparing a sample serum 
for bioanalyte detection. The feasibility of a microfluidic blood filtration device, as well as an 
immunoaffinity-based pathogen capture device, are also investigated. We show that these 
structures outperform their macroscopic laboratory counterparts. 
We also show how active fluidic structures can be used to regulate the activity of enzymatic 
reactions. For instance, we fabricated microfluidic, evaporative coolers in PDMS for temperature 
regulation, and we show that rapid, highly localized thermal cooling rates (in excess of 40 
Centigrade/second) can be achieved by endothermically mixing refrigerant and gas. We also 
demonstrate that highly localized heating can be achieved by fabricating micron-scaled and nano-
scaled platinum heaters. We demonstrate that these platinum thin-film filaments can be used as 
heaters, temperature sensors, and IR spectroscopic sources. Furthermore, we briefly describe how 
these structures can be used for locally regulating enzymatic reactions such as the polymerase 
chain reaction (PCR)--a method for copying DNA [12]. 
PCR 
PCR is a gold-standard biological technique for copying a specific nucleic acid target. In this 
technique, a chemical cocktail consisting of the nucleic acid target of interest, free base pairs 
(adenine, guanine, cytosine, thymine), short-strand complementary (to the intended target) DNA 
known as primers and DNA polymerase (an enzyme which synthesizes DNA), is rapidly heated 
and cooled between various temperature set points. If this cocktail is heated to a sufficiently high 
temperature, all the double stranded DNA polymers will unwind (as they will have sufficient 
thermal energy to break the hydrogen bonds with their complementary sequences. When this 
cocktail is cooled to a sufficiently low temperature the specific, low molecular weight primer 
sequences competitively bind to the DNA target of interest. In the presence of free nucleotides 




DNA target of interest. As this procedure is repeated over successive cycles, the quantity of 
DNA is exponential increased (ideally, by a factor of 2 each cycle; though the actual factor is less 
due to concentration-based reaction-rate effects). 
By choosing primers with sufficient specificity, both RNA and DNA targets can be copied, 
though a cDNA conversion step is required for an RNA target. This technique can be used to 
selectively amplify and then detect pathogenic or diagnostic nucleic acid targets in a serum. In 
fact, with a limit of detection as low as 6 copies/mL, quantitative PCR (qPCR) has been adopted 
as the most-sensitive, most-specific molecular diagnostic test for residual infectious disease 
measurements. In this thesis, we briefly mention how efficient thermal design on the microfluidic 
scale can be used to create low cost PCR instruments. 
PCR Instruments 
Current commercial systems for performing thermal cycling are typically large, bulky bench-top 
devices. Due to legacy geometries, these devices are designed to batch process samples in molded 
plastics (Figure 1.1) that contain a large number of individual reaction chambers (e.g. 48, 96, 
384).  
         
 
Figure 1.1 Typical dimension of a 96-well PCR plate. 
 
These reaction vessels are heated and cooled using either forced air or Peltier junctions methods. 
While the former is cheaper, it is less effective at maintaining stable temperature profiles 




temperature ramping, at the expense of significantly larger power requirements. Expensive 
electronics and bulky detection optics have precluded these devices from being used as platforms 
for low-cost, portable diagnostics. A portable PCR instrument, for example, would be particularly 
applicable to point-of-care diagnostics and developing world environments [13-15], as 
laboratory-grade instruments are not a financial or logistic possibility.        
One approach to making a low cost instrument is to lower the complexity of the instrument by 
eliminating optics. This strategy does decrease the profile and cost of a PCR instrument, at the 
expense of requiring external detection methods to report on the result of the reaction. In these 
types of instruments, the identification of the DNA product is done through DNA hybridization 
[16], gel electrophoresis [17], or light absorption/fluorescence measurements. Amplification-only 
PCR instruments are appropriate when PCR is required only to increase the quantity of DNA (e.g. 
PCR preparation before sequencing), rather than to detect the presence or initial concentration of 
specific sequence. However, decoupling detection with amplification is not a suitable solution for 
PCR in point-of-care medical diagnostics or portable molecular diagnostics instruments. 
Another strategy for increasing portability is to design an instrument that works on substantially 
smaller sample volumes. Others have tried to reduce the spatial complexity of the PCR 
instrument, by switching to novel geometry reactors built in a variety of materials such as silicon, 
silicon oxide, silicon nitride, and PDMS [18]. The limitations of these systems are that they 
require sophisticated assembly procedures to manufacture reaction chambers, resulting in systems 
that, while portable, are impractical to manufacture. For example, one device combines 
microfluidic reactions chambers defined in silicon dioxide with PDMS valves to create a single 
substrate qPCR reactor (Figures 1.2 and 1.3) [19]. The complicated microfabrication procedure 




                         
Figure 1.2 PDMS/glass hybrid reactor [19]. 
                 
Figure 1.3  qPCR system with disposable microfluidic reactors [19]. 
 
In addition to reducing the cost of materials and supplies required to run a PCR reaction, small 
volume chambers allow for smaller thermal masses, and hence more rapid thermal cycling. For 
instance, Zou notes that thermal delays while moving between temperature set-points in 
microchip reactors can be significantly less than the thermal delays in macro-tube reactors  (Table 
1.1) [20]. While this is true, the dominant delay in most modern PCR reactors is not the latency in 




Table 1.1  Thermal delays in macro-tube (30° cone tip) and in micro-chip.  
             
 
However, the cost of polymerase chain reactors can be reduced by simplifying and optimizing 
thermal control. For example, others have built PCR chambers wherein the reaction cocktail is 
pumped past isothermal zones [14] corresponding to the temperature required for the denature, 
anneal, and extend steps of thermal cycle, the PCR reaction. In this design, the PCR reaction is no 
longer delayed by heating and cooling of the sample mixture [20]. In one such device, the PCR 
cocktail is sequestered in a triangular-shaped, closed-circuit fluoropolymer tube (Figure 1.4).  
    
Figure 1.4 Geometry of an isothermal PCR device. 
 
The temperature on the two sides of the tube are regulated 95°C and 72°C by Peltier junctions, 
while the third side is passively cooled to 58°C [14]. Convection motivates the fluid to travel 
between the temperature zones, resulting in a single PCR cycle every revolution. The pitfall of 
this particular system is that the chamber geometry determines both the temperature profile and 
the cycling time. In order to change PCR conditions, a new reactor must be designed. While this 
is acceptable as a demonstration of PCR, it is not a feasible solution for a general purpose PCR 
reactor. While not lowering the cost of a PCR instrument or the PCR reactor itself, the true 





System-level efforts to miniaturize the PCR reactor have resulted in practical machines that are 
as small as laptops [21]. For example, Belgrader describes a 4-color quantitative PCR device that 
uses commodity LEDs, photodiodes, thin-film heaters, and injection molded plastics (Figure 1.5) 
[21]. By using existing mass-market components mated with a custom-designed plastic chamber, 
the authors were able to realize a low-cost, portable PCR reactor. While the advantage of this 
system is that is portable and low-cost (~$1500), it is only capable of measuring one reaction at a 
time. The authors double the spatial multiplicity by combining two sets of heaters and detectors 
onto a single platform; however, this is not a scalable solution. Any benefit in space-saving and 
cost-saving is lost if a large number of samples are to be run simultaneously (e.g. 12, 24, 48). 
            
Figure 1.5 Principle components of a laptop-sized PCR reactor [21]. 
 
Others have suggested using printed circuit board (PCB) materials to make portions of chemical 
reactors, and specifically for PCR [22]. However, prior implementations have either involved 
integrating PCB electronics for temperature measuring or heating with existing PCR cartridges 
and instrumentation, or mating PCBs with cavities extruded in other materials [20, 23]. For 
example, other groups have defined 1-5µL chambers in silicon and silicon dioxide that are 
regulated by thin-film heaters [23]. Our strategy was to leverage the fabrication capabilities of the 




circuit boards. This fabrication process had the advantage of allowing us to integrate both 
temperature sensors and heaters onboard the cartridge, allowing for extremely accurate 
temperature control. 
Initially, we opted to design PCB boards with embedded copper channels to define the reaction 
chamber. After receiving the boards, we defined the cavities by clearing the copper in these 
channels using either electrochemical and diffusion etches in ferric chloride and hydrogen 
chloride. We demonstrated that we were able to define cavities in the circuit boards without any 
change to their manufacturing process (Figure 1.6). However, to facilitate easy testing of the PCR 
reactor, we elected to transfer the fabrication procedure for these cavity devices, to a PCB 
manufacturing facilities (RigiFlex Inc., Anaheim, CA; Hughes Circuits Inc., San Marcos, CA) for 
large-scale production of a 100 cartridges. 
      
 
Figure 1.6  Topology of printed circuit board PCR chamber. 
 
We demonstrated both thermal cycling and nucleic acid amplification in a hand-held, battery 
operated, $100 PCR instrument the size of cell phone (Figure 1.7). Temperature regulation in our 
reactor was achieved by varying the power delivered to either a copper resistive heater or a 25mm 
forced-air cooling fan (Figure 1.8). Furthermore, thermal stability was achieved by configuring 
both the heater, cooler, and temperature feedback thermistor in a PID control loop. We 
successfully amplified synthetic DNA sequences corresponding to regions of interest in HIV, 




                   
Figure 1.7 Pocket PCR system. 
 
 
Figure 1.8 Pocket-sized polymerase chain reactor temperature control topology. 
 
PCR Reporting 
There are several strategies for reporting a PCR reaction. Currently, most PCR reactions are 
observed through the measurement of a fluorescent reporter specific to a particular nucleic acid 
sequence. For instance, fluorescence signals, from either intercalating dyes or fluorescent probes, 
can be used to identify and track the amplification of particular nucleic acid sequences over time. 
Both types of detection schemes offer their advantages and disadvantages. 
Intercalating dyes are organo-metallic, aromatic complexes that are often hydrophobic and are 
incorporated into the naked interstices of double stranded DNA [29]. The dyes fill the interstitial 
binding sites in the varying ratios of one dye per 4-5 base pairs (e.g. ethidium bromide) to one 




stabilized in the double helix of the nucleic acid [24, 28]. For example, the thiazole orange 
exhibits a ~20000x increase in fluorescence when bound to double stranded DNA as opposed to 
being unbound [24]. 
Interestingly, for many intercalating dyes, the fluorescence quantum efficiency was independent 
of the saturation of the binding sides, meaning the fluorescence signature directly correlates with 
the number of fluorophores that have been incorporated into the double strands. As such, the 
intensity of a fluorescence signature can be linearly correlated with the total amount of double 
stranded nucleic acid. Though the fluorescent compounds are not discriminatory in their binding 
[24], it is still possible to distinguish multiple sequences so long as they are sufficiently varying 
in length. By carefully measuring the changes in fluorescence intensity while heating up a 
cocktail containing DNA strands of different lengths slowly, it is possible to associate a particular 
target with a particular change in fluorescence. This type of “melt-curve” analysis is routinely 
performed for DNA identification. 
Another strategy for labeling DNA is to fix fluorescent compounds to nucleic acid sequences that 
are complementary to a nucleic acid target of interest. For example, one can fix two 
chromophores to the 5’ and 3’ ends of a short, single-stranded DNA sequence (Figure 1.9) in such 
a fashion that is complementary to itself. The chromophore at one end is designated as the 
fluorophore, while the chromophore at the other end is designated as the quencher. Even when 
excited, the fluorescence emission from the fluorophore will be damped when if it is in close 
proximity to the quencher. This interaction is governed by fluorescence energy transfer [25]. 
At lower temperatures, the probe forms a hairpin structure with itself that brings the fluorophore 
into close proximity with a matched quencher. In this configuration, the excited fluorescence 
emission is minimal, as the two chromophores are within a requisite quenching radius. As the 
temperature is increased, the probe has sufficient thermal energy to unwind. If the probe is 
designed to be complementary to a particular DNA target, it will bind to that target, if it is 
energetically favorable. When that occurs, the fluorophore and quencher are sufficiently 
separated such that there is appreciable fluorescence. In this way, these molecular probes can be 
used to associate particular fluorescence signatures with particular DNA targets. 
Dual labeled nucleic acid probes can also be designed in another fashion. As the Taq polymerase 




fluorophore and the quencher [26, 27]. Once the cleavage occurs, the quencher and fluorophore 
are no longer in close proximity at any temperature, and the fluorophore will exhibit a strong 
fluorescence signature. These probes are called TaqMan probes, and are a standard tool for 
reporting on PCR reactions. By carefully selecting both the fluorophore and the quencher that are 
conjugated to the nucleic acid strand, the emission signature can be controlled. 
 
Figure 1.9 PCR reporting probes. 
 
Multiplexed Reporting 
Multiplexed reactions offer significant advantages and efficiencies, e.g. the use of the same 
chamber to run multiple reactions, the performance of parallel reactions on the same sample, and 
the ability to extract complex information from the sample in a fast and efficient way. However, 
to achieve these benefits and efficiencies, multiplexed assays require complex reporting 
mechanisms. These mechanisms involve coding of the “question” and decoding of the “answer” 
of the assay. Typical such mechanisms involve spectrally resolved fluorescence and 
chemiluminescence, or spatially resolved “single-color” assays, or temporally resolved, or by a 
combination thereof. 




assay where a single color is used for the detection (usually an intercalator dye). Single-
chamber multiplexed PCR is an example of a spectrally encoded multiplexed assay, as the signal 
is collected from the same locus (e.g. the reaction chamber) but resolved spectrally as each PCR 
probe fluoresces in a different band of the spectrum. Sanger sequencing is an example of 
spectrally and spatially resolved multiplexed assay, as each terminated strand is coded with one 
of four fluorescence “colors” to report the terminating nucleic base, while the position of the base 
in the sequence is reported by the location of its fluorescence signal in the electrophoretic gel. 
Fluorescence barcodes are also used, e.g. the Illumina system, where individual beads are coded 
with a combination of fluorescence probes, and then they are distributed across an array for 
individual decoupled readout. In the Helicos system for single molecule DNA sequencing, 
millions of strands are immobilized across a substrate and then sequencing-by-synthesis is 
performed by building the complementary strands using nucleotides tagged with one type of 
fluorescence dye per base type. The result is a spatially distributed array where spectral resolution 
determines the base, while temporal resolution produces the base location in the sequence by scan 
after every extension reaction. 
Current PCR instruments and methods allow for the multiplexing reporting of PCR reactions by 
associating a particular wavelength fluorophore with a particular nucleic acid target. Regardless 
of the labeling strategy, the information from a single PCR reaction can be wavelength division 
multiplexed in this fashion. 
In this thesis, we show that by selectively combining different fluorescent labels for a single 
nucleic acid target, we can identity a larger number of nucleic acid targets than the number of 
wavelength channels available. We demonstrate this technique by designing different two super-
color codes for Taqman qPCR: error-correcting qPCR and binary-coded qPCR. The former has 
the benefit of using a biochemical checksum to ensure that a particular reaction has run to 
completion, while lowering the multiplexed capability of the super-color coded reaction. The 
latter code maximizes the number of targets that can be coded using this technique, by monitoring 





Figure 1.10 Binary-encoded PCR 
 
Our coding/decoding technique offers an inexpensive way to multiplex through spectral 
resolution while avoiding the need for temporal and spatial resolution. More specifically, we offer 
a method to use fluorescence tags to overcome the multiplexing limitation to four colors with 
digestion probes in PCR, which is normally imposed by the wide emission spectra of standard 
fluorescence dyes. In this thesis, we explain the workings of the method, which would result in 
multiplexing to at least 6 independent readouts by fluorescence and an additional at least 3 
readouts by fluorescence resonance energy transfer. We also explain how the two can be 
combined without crosstalk, resulting in an assay multiplexed to 9 independent readouts. Thus 
this method more than doubles the available bandwidth for multiplexing without requiring new 
instrumentation or expensive new reporting constructs. In fact, the implementation of the coding 
and decoding is rather straightforward and easily incorporated in modern assays. 
Thesis Outline 
In chapter two of this thesis we describe micro-scaled and nano-scaled platinum sensors for 
heating and thermometry. These sensors allows for highly localized temperature regulation, 
applicable for regulation of enzymatic processes like the polymerase chain reaction. We show 
that these heaters can also be used for on-chip IR spectra generation. In chapter three, we show 
how microfluidic fabrication techniques can be used to create a PDMS-based microfluidic blood 
filtration device. Such a device is applicable for the upstream sample preparation (e.g. sample 




combinatorial codes for labeling and reporting on colorimetric assays such as ELISA and 
qPCR. In chapter five, we demonstrate fluorescence immunoassays in a miniaturized PDMS 
laboratory-on-chip. We show how the benefits in scaling geometries allows us to process 100 
chemical reactions simultaneously. In chapter six, we report on a microfluidic immunoaffinity 
chromatography device that can be used to concentrate nucleic acid for downstream PCR 
analysis. In chapter seven, we describe the microfluidic evaporative coolers in PDMS. These 







C h a p t e r  2  
MICROSCALED AND NANOSCALED PLATINUM SENSORS 
Summary  
We show small and robust platinum resistive heaters and thermometers that are defined by 
microlithography on silicon substrates. These devices can be used for a wide range of 
applications, including thermal sensor arrays, programmable thermal sources, and even 
incandescent light emitters. To explore the miniaturization of such devices, we have developed 
microscaled and nanoscaled platinum resistor arrays with wire widths as small as 75 nm, 
fabricated lithographically to provide highly localized heating and accurate resistance (and hence 
temperature) measurements. We present some of these potential applications of microfabricated 
platinum resistors in sensing and spectroscopy. 
Introduction 
Microlithography and nanolithography techniques can now be applied toward the miniaturization 
of a wide variety of sensors and actuators, leading to their integration into chip-based analysis 
systems. On-chip sensors enable the monitoring and regulation of many chemical and biological 
samples in parallel, and reduce the individual device cost, following the trend toward more 
complex and functional microelectronics through lithographic printing. 
Platinum wires have been used for resistive heaters and incandescent light sources since the early 
1820s. Platinum does not oxidize, making it a good candidate for vacuum-free, miniaturized 
visible and infrared sources, heaters, and thermometers. Applications of these microscale thermal 
control systems include chemical analysis, gas chromatography [30-33], microcalorimetry as well 
as thermal regulation of polymerase chain reactors [34] and even micropropulsion systems [35]. 
Miniaturization of these devices is particularly beneficial for systems that require independent 
thermal control over many reactions or wide band spectroscopic light sources; the low thermal 
mass of microfabricated heaters enables greater accuracy in measurement, faster heating and 
cooling rates, while requiring lower power than macroscopic systems. 




of −200°C to 500°C, and are well suited for the thermal measurement and control of wide array 
of chemical processes [34]. In particular, platinum RTDs exhibit a high accuracy and 
repeatability of temperature measurements when compared with thermocouples for temperatures 
below 600°C [36]. In this paper, we present on-chip thin-film, micron-sized platinum resistive 
thermometers as convenient on-chip thermal control systems and IR light sources. 
Materials and Methods 
We fabricated arrays of platinum microresistors and nanoresistors on alumina coated oxidized 
silicon wafer substrates. Fabrication starts with the growth of 160 nm of wet thermal oxide on a 
<100> silicon wafer. Subsequently, a 150 nm layer of alumina (Al2O3) and a 150 nm layer of 
platinum were sputter deposited on the surface using a direct current (dc) magnetron sputtering 
source [37]. The approximate film thicknesses were confirmed by scanning electron microscopy. 
After the complete stack of materials was deposited, a milling mask pattern was then defined 
using standard photo-lithographic techniques. The resistor pattern was transferred by milling 
through the platinum and aluminum oxide, into the glass (to remove shunt thermal resistances), 
using a radio frequency (rf) plasma-based argon mill (Figure 2.1 top left inset).  
  
Figure 2.1 SEM image of Pt microresistors. Insets: cross-section (top right); dimensions (top 
left). 
 




chips to a low- voltage rf oxygen plasma. These platinum resistors consist of a series of twenty 
serpentine platinum wires with 1-4 µm widths, and cover an area of 100 x 200 µm2
 
on chip 
(Figure 2.1). Finally, selected microresistors were processed to create nanometer-wide 
“nanoresistors” (Figure 2.2) by using an FEI Nova 200 focused ion beam (FIB) system. The 
resistor linewidths were reduced from 1-4 µm to as small as 75 nm. This technique was utilized 
since it allows for mesoscaled structures to be fabricated using the same set of optical lithography 
masks. 
          
Figure 2.2 SEM image of Pt nanobulb (FIB-thinned microresistor). 
 
Results and Discussion 
Before temperature-benchmarking, the microresistors were annealed by resistive-heating with a 
constant power of ~1.5 W for 10 min to ensure thermal stability. These annealed resistors show 
considerably better relative tolerances on each chip than non-annealed resistors with a standard 
deviation of resistance σ=2.1% (sample size n=20) for annealed resistors and σ=48% (sample size 
of n=194) for non-annealed resistors. We believe that this annealing step allows the platinum 
thin-film to electromigrate in a controlled way and improves the reliability of the resulting 
heaters. This helps to minimize resistor failures during subsequent heating and measurement and 
has allowed the annealed resistors to be driven at higher power than non-annealed resistors. 
To test the heating and temperature sensing capabilities of the resistors, a dc power supply was 
connected to the heater resistor and adjusted to deliver power in steps of 250 mW. The resistance 
of each adjacent resistor was manually probed and measured in order to characterize the thermal 




resistance (TCR) [0.003927 (Ω cm)/°C] [38] of platinum, we can relate resistance 
measurements of the platinum structure to the temperature of the substrate. The resulting 
temperature profile across the resistor array (Figure 2.3) shows that the temperature decreases 
with distance from the heating element and with decreasing heater power. Thermal isolation, 
provided by the SiO2 film, ensures that the heating is confined to the surface Al2O3. 
      
Figure 2.3 Temperature versus distance for resistor array for various driving powers. R0 is 
the heating element. R1-R9 are measurement elements. 
 
Furthermore, the platinum resistor structures can be driven with enough power to exhibit 
luminescence in the visible range (Figure 2.4).  
     
Figure 2.4  Normalized blackbody emission spectrum of Pt microbulb, and spectrum 





This process can be enhanced by creating small, highly resistive regions within the platinum 
conductors. The intense localized heating of the platinum structures caused them to emit as 
blackbodies with components in the orange-red region of the visible spectrum. Spectra of light 
emission from these incandescent platinum filaments were extracted using an Acton cooled 
charge-coupled device camera. We compensated for the spectral sensitivity of the camera and 
optical system using a 3100 K near-blackbody light source. Furthermore, we were able to 
characterize the peak non-normalized (i.e., not corrected for detector optics) emission frequencies 
as a function of applied filament power across an individual resistor, and these have been 
summarized in Table 2.1. 
Table 2.1  Peak emission wavelength vs power dissipation. 
 Measured peak wavelength (nm) Input Power (W) 
Nanobulb 719.28 5.40 
Nanobulb 718.02 5.92 
Nanobulb 706.67 6.62 
Nanobulb 701.62 7.22 
Macrobulb 733.36 38.57 
 
Using standard finite element analysis techniques, we were able to validate these spectral 
measurements. We modeled conduction, radiation, convection, and Joule heating using a nominal 
1x1 cm chip with microresistors and a 5 W power source. Our model includes the chip mount 
used during the measurements, which was modeled as a heat sink with 9000 W/K m2
 
(as 
measured). The simulated blackbody emission spectrum, produced using the surface temperatures 
created by the chip is shown in Figure 2.4. The simulated peak temperature was approximately 
1900 K, slightly above the melting point of platinum. After optical compensation for our 
measured spectra, we found that the simulated peak and the predicted peak from Wein’s law 
matched well with our measurements (Figure 2.4) [39, 40]. From these data, we conclude that the 
platinum filaments are heated slightly beyond their melting temperature, causing them to radiate 
in the near-visible and visible frequencies. 
These high temperatures eventually led the bulb to failure, most likely caused by the melting and 
evaporation of the platinum from the substrate material. In the future, active cooling or physical 






The on-silicon fabrication of the resistive elements allows for integration of complex control 
circuitry for thermal control. For example, we envision that such a device can be used for 
applications such as microcalorimetry. These resistor arrays can be used to quantify the 
exothermic or endothermic nature of reactions. Ultimately, when electronics and fluidics are 
integrated with these platinum heaters, we envision these platinum resistance thermometers to be 
used within chip-based gas chromatography systems, accurate thermal controllers for microscopic 









C h a p t e r  3  
MICROFLUIDIC BLOOD FILTRATION DEVICE 
Summary 
Rapid decentralized biomedical diagnostics have become increasingly necessary in a medical 
environment of growing costs and mounting demands on healthcare personnel and infrastructure. 
Such diagnostics require low-cost novel devices that can operate at bedside or in doctor offices 
using small amounts of sample that can be extracted and processed on the spot. Thus, point-of-
care sample preparation is an important component of the necessary diagnostic paradigm shift. 
We therefore introduce a microfluidic device which produces plasma from whole blood. The 
device is inexpensive, reliable, easy to fabricate, and requires only 3.5 kPa pressure to operate. 
The device is fully compatible with microfluidic diagnostic chips. The output 23- gauge 
microtube of the former can be directly plugged into the input ports of the latter allowing 
immediate applicability in practice as a sample-prep pre-stage to a variety of emergent 
microfluidic diagnostic devices. In addition, the shown approach of filter encapsulation in 
elastomer has principle importance, as it is compatible with and applicable to microfluidic 
sample-prep integration with analytical stages within the same elastomeric chip. This can 
eventually lead to finger-prick blood tests in point-of-care settings. 
Introduction 
Microfluidic technology allows for very precise manipulation of minute samples of fluid in 
controlled environments [48]. Furthermore, microfluidic chips can be mass-produced at low costs 
[48] and show potential as small, cheap, and low-powered devices for point-of-care medical 
testing [49]. Analytical microfluidic devices have already been demonstrated for antigen 
detection [50], viral detection [51], and quantification of various blood protein analytes in human 
serum [52] and human plasma [53]. 
However, such devices cannot be used directly with untreated patient samples because they are 
generally designed to operate with prepared serum or plasma, while the patient can only offer 




first, e.g. coagulation and centrifugation for serum, and anti-coagulation and filtering for 
plasma. Thus, the complete diagnostic procedure cannot be fully miniaturized into a portable 
point-of- care format until sample preparation is miniaturized as well. 
Such miniaturization is complicated due to the fact that serum preparation uses centrifugation to 
remove the coagulate, a technique that cannot be directly incorporated into a microfluidic chip. 
The alternative is to filter the coagulate, but this usually results in rapid clogging of the 
microfilter. Consequently, researchers have concentrated on the production of plasma on-chip, 
generally using poly(dimethylsiloxane) (PDMS) [55] as the material of choice, as PDMS is 
inexpensive, disposable, and chemically and biologically inert. The more recent results are 
encouraging [56-59]. 
However, the devices tend to produce only a relatively small amount of sample before becoming 
clogged [58], or they leak thrombocytes into the output [59], which might interfere with the 
proper function of the downstream diagnostic assay. In addition, such devices generally consist of 
filters sealed between layers of PDMS and/or glass, or the filter is defined in the PDMS itself 
before being assembled to the glass substrate [58, 59]. These configurations limit the filter surface 
(due to building the filter perpendicularly to the layer surface) and/or the applicable filtration 
pressure (due to the danger of sealing failure at the materials’ interface in PDMS-glass devices). 
Consequently, we have designed and fabricated a microfluidic blood filter tightly sealed within a 
single molded piece of PDMS. The device is integrated with an anticoagulant ethylene-diamine- 
tetra-acetic acid (EDTA) coated capillary tube. Whole blood from a single fingertip prick is 
passed through this tube and through specially-designed filter paper embedded in the PDMS 
device. The produced plasma exits through a 23-gauge steel microtube, allowing the device to 
easily interface with other standard microfluidic devices. In comparison to its microfluidic 
predecessors, the reported device has significantly increased the filtering area, making it less 
susceptible to clogging and enhancing its filtering capacity. Also, our device makes use of a more 
efficient filtering material, which further improves its overall filter characteristics. Finally, the 
complete encapsulation of the filter inside an elastomeric device makes it less susceptible to 
failure and leakage. 
The reported device is also an important demonstration of a fully functional filter encapsulated in 




integrated within the same chip, eliminating the dead volume between sub-stages and 
eventually leading to point-of-care finger prick blood tests in fully integrated inexpensive 
analytical systems. The reported device is a technical step towards the future of biomedical 
diagnostics. 
Materials and Methods 
The PDMS blood filter is fabricated using polymer casting around a machined aluminum mold. 
Figure 3.1 depicts the mold alongside the finished device. The mold holds a membrane blood 
filter in place and defines a fluidic circuit between input and output ports compatible with 
commercially available anticoagulant finger prick blood draw capillary tubes and microfluidic 
23-gauge tubes, respectively. The device is cast as a single piece. 
   
Figure 3.1 Aluminum mold and PDMS cast with filter material embedded. 
 
A two-piece aluminum replica mold is connected with Allen bolts. The bottom piece contains a 
24-gauge steel pin press-fit into the aluminum to mold a hole in the PDMS that seals tightly to the 
standard 23-gauge tubes typically used in microfluidic devices. The top piece consists of a 
cylinder designed to mold the PDMS in a fashion such that capillary tubes can be inserted and 
sealed. The top mold piece contains four holes, two of which are threaded and correspond to 
tapped holes on the bottom piece. These are used to compress the filter between the top and 
bottom cylinders, ensuring the creation of a leak-proof channel. The additional two holes are 
threaded and have no corresponding holes on the bottom piece. These are used to easily back the 




The two rounds of the mold, which allow for the capillary tube integration and the 23-gauge 
pin interface, are connected and serve to compress the blood filter paper. The filter paper is then 
placed between the top and bottom pins, and Allen bolts are used to secure it in place. There are 
several inexpensive and readily available filter materials suitable for this device. The BTS-SP 
series from Pall Corporation (East Hills, NY) was used in fabrication and testing. The BTS-SP 
media (Figure 3.2, www.pall.com) features a highly asymmetric membrane engineered for 
plasma production from whole blood. The graduated pore structure of the filter consists of larger 
pores on the upstream side, with finer pores on the downstream side. This structure allows red 
and white blood cells to be captured in the larger pores while the plasma wicks into the smaller 
pores on the downstream side of the membrane. The large pore side of the media served as an 
absolute cell exclusion zone and performed very well in our device. 
             
Figure 3.2 Micrograph of the BTS-SP filter based on asymmetry polysulfone membranes. 
 
The PDMS device is cast in a procedure similar to conventional micro-soft lithography [60]. The 
mold is prepared and placed into a Petri dish. Uncured PDMS prepared in a 10:1 ratio is poured 
into the dish, covering the mold [60]. The dish is left to degas in a vacuum chamber to remove air 
bubbles from the PDMS mixture. The device is allowed to cure in an 80°C oven for one hour. 
The cured PDMS is removed from the dish and the device is cut from the underlying PDMS 
substrate. The Allen bolts holding together the cast are removed, bolts are inserted into the tapped 
separation holes, and the mold is slowly backed out of the PDMS. This allows the blood filter 
paper to remain intact within the microfluidic device. The choice of capillary tube is specific to 
the test carried out, as different anticoagulants are needed for different analyses. The capillary 




Westwood, MA) had EDTA as an anticoagulant. These capillary tubes are used in medical 
facilities as a standard finger prick blood draw and are available with several different 
anticoagulant formulations. 
Results and Discussion 
Mouse blood was used to test the effectiveness of the device. Aliquots of the blood sample were 
stored at 4°C during testing; EDTA was used to prevent the blood from clotting when stored. 
When testing, 1 mL aliquots of mouse blood were drawn into a blood draw glass capillary tube 
inserted into the filter (Figure 3.3). The blood was forced through the filter under 3.5 kPa of dry 
nitrogen supplied by a hose attached to the capillary tube. This pressure was chosen to 
demonstrate that very little pressure is necessary to flow blood through the filter, and the blood 
filtered through very quickly under these conditions. The filter was able to collect 80-100% of the 
available plasma, typically half the total volume of the blood. As microfluidic applications 
generally require tens to hundreds of nano-liters of plasma for analysis [52, 53], our tests 
demonstrated this filter was capable of handling a volume of blood large enough for many uses. 
            
Figure 3.3 PDMS blood filter integrated with a blood-draw glass capillary tube and 
connected to a microfluidic analysis chip through a 23 gauge steel tube. 
 
The filter was attached to a PDMS device containing a microfluidic channel 100 µm in width and 




the tube is held tightly by the material of the filter device, while its lower end is held tightly by 
the material of the analytical device (Figure 3.3). Since these are very light structures, additional 
mechanical support was not necessary. Flow in the channel was imaged with blood both passed 
through the filter and without the filter. Figure 3.4 shows the blood sample with and without 
filtration, demonstrating successful cell elimination. The device filtered more than 2 mL without 
clogging. Based on our experience, we believe the limit of the current configuration is about 5 
mL filtered before clogging. 
          
Figure 3.4 Comparison between filter output (left) and unfiltered whole blood (right) attests 
to the quality of the filtering. Each channel is 100 µm wide and 10 µm tall. 
 
This design has important advantages over traditional planar microfluidic filters that rely on 
sealing blood filters between layers of PDMS, or PDMS and a solid substrate. Such devices can 
effectively use only the thinnest of filters, and require epoxy, thermal or plasma bonding to create 
tight seals, complicating fabrication and creating concerns of leakage. By contrast, the presented 
device can use a variety of filtering materials, making the filtering area less limited and increasing 
the overall reliability and robustness of the device. Finally, the casting method used allows for 
high reproducibility and low cost of production due to the low cost of PDMS and the reusability 
of the mold. 
In principle, similar filtering systems can be assembled by combining commercial filters with 
macrofluidic components, e.g. luer-stub adaptors and connectors. However, each has a dead 
volume, which leads to losses of sample as a flat initial investment. In contrast, our method can 




devices by design and during the latter’s fabrication. The long-term utility of such an approach 
will be the elimination of dead-volume losses and overall system integration and miniaturization. 
The result would be diagnostic systems where the sample-prep and the measurement stage are 
built inside the same disposable device by simple and economic means, while the elimination of 
many microliters of dead volume would mean the ability to use such devices for finger prick 
blood tests in point-of-care settings. Thus, the reported device and approach have important 
implications for the future of bioanalytical diagnostics. 
The system integration described above would also make device fabrication more streamlined, as 
the process of encapsulation of the filter will be incorporated as part of the industrial fabrication 
of the overall device. For example, the filter could be sandwiched between consecutive layers in a 
multi-layer microfluidic chip. Alternatively, the filter can first be encapsulated into an elastomer 
slab as done here, and then be used as one of the layers in the overall multilayer chip. Both 
techniques are fully compatible with modern industrial approaches of microfluidic fabrication, 
e.g. such as successfully practiced by Fluidigm Corp. 
Conclusion 
We have demonstrated a simple, reliable, and disposable PDMS blood filter device that produces 
plasma from whole blood while using nominal positive pressure. Casting the device as a single 
piece ensures leak-free functionality without chemical sealants or complicated bonding 
procedures. Additional advantages include a larger filtering area, more efficient filtering material, 
and compatibility with conventional PDMS chips. It contributes as an important sample-prep 
function to microfluidic diagnostic systems, which promise to shape the future of biomedical 








C h a p t e r  4  
SUPERCOLOR CODING METHOD FOR LARGE-SCALE MULTIPLEXING OF 
BIOCHEMICAL ASSAYS 
Summary 
We present a method for the encoding and decoding of multiplexed biochemical assays. The 
method is the first to solve the degeneracy problem in “supercolor” coding. It allows for a 
theoretically unlimited number of independent targets to be detected and uniquely identified in 
any combination. Herein, we describe three coding schemes under the same method, and show 
experimental proofs-of-principle using Taqman PCR. Nonetheless, the method is not limited to 
PCR or fluorescence, but would benefit any assay whose reporting mechanism has “color” and 
“intensity”, or their equivalents. The method enables the implementation of large panels of tests 
in point-of-care, near-patient, and low-resource biomedical diagnostics. Also, the method offers a 
remarkable increase in the productivity and information richness of existing PCR assays and 
systems, with correspondingly broad impact to clinical diagnostics and digital PCR. 
Introduction 
Multiplexed reactions offer significant advantages: the performance of parallel reactions on the 
same sample, the use of the same chamber to run multiple reactions, and the ability to extract rich 
information from the sample in a fast and efficient way. However, to achieve these benefits, 
multiplexed assays require complex reporting mechanisms: spectrally resolved fluorescence or 
chemi-luminescence (PCR, ELISA) [62], spatially resolved assays (microarrays, gel 
electrophoresis) [63], temporally resolved signals (capillary electrophoresis), or combinations 
thereof (Sanger sequencing) [64]. 
Among these, fluorescence has been the undisputed leader for the past 15 years due to its long list 
of desirable features: compatibility with biochemical assays, small size of the labels, easy 
conjugation to molecules of interest, affordability, low toxicity, stability, robustness, detectability 
with inexpensive optics, and ability to be combined with spatial arrays. However, fluorescence-
based multiplexing has been limited by the large width of the emission spectra of standard 




measured signal can be correctly decoded into a unique outcome [65].  
As a result, the typical coding scheme has been to assign one color per target, i.e. M=N, where M 
is the multiplexing factor and N is the number of independent “colors”. With standard 
fluorophores, this has meant that only 4 to 6 questions are typically asked of the same sample at 
the same time [66, 67]. Wherever higher factors of multiplexing are required, the solution has 
been to combine fluorescence with aliquoting, spatial arraying, or sequential processing [68]. 
However, those lead to labor-intensive workflow and/or significantly more expensive and bulkier 
systems. Thus, it would be highly beneficial if the multiplexing factor were increased through 
spectral coding only. 
Early attempts at “supercolor” multiplexing (M>N) have been only partially successful. 
“Chromosome painting” [69] allowed for FISH-based identification of 24 chromosomes, while 
two PCR Taqman-based schemes could identify eight foodborne pathogens [70] or fifteen types 
of HPV [71]. However, the first scheme made use of the application-specific condition that each 
chromosome was also spatially resolved from the others, while the other two schemes assumed 
that no more than one of the targets is present at a time. If these restrictions are relaxed, all three 
schemes produce “degeneracy”, i.e. the same test result decodes into more-than-one possible 
outcomes. A general multiplexing scheme (e.g. coding for panels of infectious diseases, drug- 
resistant bacterial strains, foodborne pathogens, or genetic markers) cannot allow ambiguity of 
outcome and cannot assume that only one target is present at a time. 
Herein we report on a novel coding method that is the first to solve the degeneracy problem and 
thus the first to ensure the unambiguous identification of any combination of present targets. 
Also, its multiplexing factor M is mathematically unlimited and is practically much larger than 
the number of available colors (M>>N). Thus our method is a major breakthrough in the field. 
As the method uses standard fluorophores and oligos, it is easily implemented with the existing 
oligo-synthesis techniques and measurement infrastructure. Once applied in practice, the method 
would produce a major increase of the productivity of the existing fleet of machines (e.g. for 
PCR, qPCR, digital PCR) as no changes in the hardware would be needed to accommodate the 
new multiplexing capabilities. 




different target is a valid if expensive and labor-intensive multiplexing strategy [72-80]. 
However, the amount of sample is rather limited in point-of-care diagnostics [81], while the viral 
load in a positive patient can be very low. As a result, any splitting is undesirable, because the 
resulting amount of analyte in each aliquot may fall below the detection limit of the assay. In 
contrast, our method would pose multiplexed questions to the whole sample, thus avoiding 
aliquots and the loss in sensitivity. Hence, our method is particularly significant to point-of-care 
PCR assays, where it would also allow for cheap disposables to test for large panels of infectious 
diseases and multiple strains of drug-resistant bacteria. The low cost of its implementation makes 
it even more important to diagnostics in low-resource settings. 
Materials and Methods 
Five nucleic acid pathogens of clinical relevance were chosen for this study: Human 
Immunodeficiency Virus 1 (HIV-1), Plasmodium falciparum (Malaria), Herpes Simplex Virus-2 
(HSV-2), Mycobacterium tuberculosis (TB), and Dengue Virus Type 3 (Dengue Fever). Two 
targets of diagnostic relevance on the HIV-1 genome [82-85] (26–29), p17 and poly protease, 
were selected from the Los Alamos National Laboratory HIV-1 reference sequence [86] (30). A 
diagnostic sequence from the Malaria falciparum ChR7 gene [87, 88] (31, 32) was obtained from 
the UCSC Plasmodium falciparum Genome Browser [89] (33). A sequence for Herpes Simplex 
Virus-2 [90] (34) was synthesized from the sequence obtained from the European Molecular 
Biology Library [91] (35). Similarly a diagnostic sequence for rpoB gene in Mycobacterium 
tuberculosis [92-94] (36–38) was synthesized from a sequence obtained from the European 
Molecular Biology Library [95] (39). A PCR diagnostic sequence for Dengue Virus Type 3 [96] 
(40) was obtained from the National Institute of Health genetic sequence database [97] (41). 
All oligonucleotides were synthesized by Integrated DNA Technologies (Coralville, Iowa). 
Diagnostic sequences were input into IDT’s OligoAnalyzer 3.1 tool. Probes and primer pairs for 
each target were chosen, from the OligoAnalyzer’s set of generated sequences, to minimize 
homology with un-intended targets, probes and primers. TaqMan sense probes for all targets were 
synthesized with a fluorophore at the 5’ end and a quencher at the 3’ end. Sequence information 
is tabulated in Appendix A Tables S-3 to S-8. Nucleic acid products were synthesized and 





Results and Discussion 
The crux of our method is the combined use of “colors”, the multiplicity of signal intensity, and 
mathematical strategies to circumvent degeneracy and ensure an infinite number of unique codes 
that can be unambiguously decoded in any combination of occurrence. While the method is not 
limited to fluorescence, PCR, and Taqman probes [98], they are the natural choice as a system for 
proof of principle for the method. 
Taqman probes are short pieces of DNA that have a fluorophore on one end and a quencher on 
the other end. If the target sequence is present, the probe and primer hybridize to it. As the 
polymerase extends the primer, its 5’ exonuclease activity breaks up the probe sequence. The 
released fluorophore and quencher separate by diffusion, and so the fluorophore emits 
fluorescence signal. Conversely, if the target sequence is not present, the probe remains intact, so 
the quencher prevents fluorescence emission. The end result is a strong fluorescence signal when 
the target is present and a weak or no signal when the target is not present. 
Standard fluorophores have wide emission spectra, so to avoid overlap and false positives, only a 
few colors (typically four) are used simultaneously in multiplexed assays. Each color is assigned 
to a different Taqman probe. Then, the presence or absence of a sequence is judged by the 
fluorescence signal in the respective color. For example, if the color set is named {blue, green, 
yellow, red} by excitation, a traditional experimental result of 1100 means the sequences coded 
by blue- and green-excited fluorophores are present, while the other two are absent. 
Unlike the traditional approach, our method generally uses more than one color per sequence. 
Table 4.1 shows one such coding scheme in four colors.  
Table 4.1 Combinatorial coding of Targets 




Code 1000 is assigned to a control sequence Z that will always be present and should always 
amplify [99]. All sequences have a probe in the control color. This design ensures that the 
multiplicity of the signal intensity in the “control” color reports the number of unique sequences 
that have successfully extended and are thus present in the sample. 
Mathematical symmetry dictates that any color can be the control color. However, as the highest 
multiplicity would likely be observed in the control color, it makes sense to choose it to be the 
color that is best detected in the particular system. The Roche Lightcycler 480 used for the 
experimental proof has only a blue excitation, while the other colors count on wide excitation 
tails. Hence, blue was the logical choice here. 
The possible measurement results and their decoded meaning in terms of sequences present are 
shown in Table 4.2. Three conditions have been stipulated: First, the positive control always 
produces a positive outcome, i.e. it works appropriately. Second, in each color, the signal is 
additive and scales in the same way with probe concentration, regardless of which probe it comes 
from. Third, in each color, each probe produces the same unit of signal. Essentially, this means 
the signals are additive and digital. Ensuring the first condition is just a matter of proper 
preparation of the assay. The second condition is attainable under fluorescence. In practice, the 
third condition need only be approximately right, as we show further below. 
A measurement outcome is denoted as a sequence of signal multiplicities in the respective 
“colors”. Each multiplicity is calculated within its own color. For example, outcome 4321 means 
the sample’s measured intensities are 4x in blue, 3x in green, 2x in yellow, and 1x in red. This 
outcome is valid, because it can be achieved by adding sequence codes from Table 4.1, so it is 
found in the decoding Table 4.2. It produces the answer ZCFG, which means only sequences Z, 
C, F, G are present. Conversely, the outcome 4000 is invalid, because it cannot be achieved by 
adding sequence codes from Table 4.1 in a digital fashion, and thus is not listed in Table 4.2. An 
invalid outcome means that the assay malfunctioned in the particular experiment. This logic filter 
















Table 4.2 shows all the valid answers, and thus it is the exhaustive set for the encoding Table 
4.1. To see this, let’s go through the decoding Table 4.2 rank-by-rank. “Rank” is defined as the 
number of present sequences, which under the encoding Table 4.1, is equal to the multiplicity of 
the blue bin. The lowest rank is 1, with a single valid outcome of 1000 and a test result of Z. This 
means only the control sequence was present. At rank 2, the control sequence and one other are 
present, so there are 7 such cases. At rank 3, the control sequence and two other sequences are 
present, so the number of distinct results is a combination of 7 choose 2, or 7!/(5! * 2!)=21. At 
rank 4,5,6,7, and 8, the number of distinct results is 35, 35, 21, 7, and 1, respectively. Table 4.2 
shows the same numbers of results in each rank, so the table is exhaustive. 
In “supercolor” multiplexing, degeneracy is the phenomenon wherein the same valid outcome 
corresponds to multiple distinct combinations of present sequences [70, 71]. For example, 
outcome 5233 in Table 4.2 is degenerate, because it can be decoded as either ZADFG or ZBDEG. 
As a counterexample, outcome 3110 is not degenerate because it is decoded to a single result 
(ZBC). 
It turns out degeneracy can be eliminated. For example, outcome 4112 is valid and can be 
decoded as either ZABE or ZACD. So, if we drop sequence D from the set, the test result ZACD 
is no longer possible, so the only remaining test result associated with outcome 4112 is ZABE. 
Using this idea, we have found out that dropping any two of {D, E, F} completely eliminates 
degeneracy, while the coding remains “supercolor” (M>N) as 6 sequences are unambiguously 
identifiable in any combination while using just 4 colors. 
To demonstrate the scheme experimentally, we chose representative sequences from important 
diseases and designed respective primers and probes labeled with FAM, Cy3, ROX, and Cy5. The 
chosen coding was 1000 (HIV PolyProt), 1100 (HIV P17), 1010 (malaria), 1001 (herpes), 1101 
(tuberculosis), and 1111 (dengue). We ran separate positive controls for each sequence, as well as 
the full panel for several combinations of sequences present. The experimental details are in the 
supplemental materials. 
The signals of the positive controls were added to produce the expected cumulative signal for 
every possible combination of present sequences, in each color. Each expected cumulative signal 
was plotted as its own level in a “chromatogram”. Expected cumulative signals corresponding to 




this for all colors produced a level and band structure, against which the experimental results of 
each combination could be judged. Figure 4.1 shows the chromatograms of experimental 
combinations 4112, 3121, and 3102. The experimental results for each combination in each color 
are shown by black dots. 
  
Figure 4.1 Chromatogram of multiplexed experiments. 
 
“Calling” the results to determine multiplicity in each color relies on three criteria: First, the 
analog result of fluorescence signal must be converted into a digital result of the multiplicity. So, 
if the dot falls inside a band, then the multiplicity of that band is the answer. If a dot is in between 
two bands, the result can be either multiplicity but not both. Second, illegal results can be 
excluded or considered a failed experiment. Third, if the dot is between two legal results, the 
“called” result is the one whose band is closer to the dot. 
Using these criteria, the first experiment is “called” 4112, which is the correct answer. The 
second experiment should be “called” 2121 or 3121, but 2121 is illegal, so the result must be 
3121, which is the correct answer. The third experiment is 3102 or 3101, both of which are legal, 
but the dot is clearly closer to 3102, so that should be the call, and that is the correct answer. 





The results show a trend of slightly lower combined signal than what would be expected from 
a simple summation of positive-control signals. This leads us to believe that the combination is 
not perfectly linear, so there are additional effects, for which the chromatogram construction does 
not account at present. We conjecture that this particular effect has to do with the absolute 
concentration of quenchers. The higher the absolute concentration of quenchers, the larger the 
percentage of reaction volume they “black out”, so the same percentage of released fluorophores 
fails to contribute to the cumulative signal. One solution is to use low concentrations of probes, so 
that the percentile loss is negligible, regardless of how much of the quencher is released. This 
issue is a subject of ongoing research. 
Figure 4.1 shows that each rank containing multiple combinations has a relatively wide band. The 
width of the band is ultimately the difference between the highest and lowest cumulative signals. 
If all positive controls in the particular color produced exactly the same fluorescence signal, then 
the width of each band would be zero. Since instead those signals are somewhat different, the 
resulting bands are relatively wide. Fortunately, there is a simple means to tighten the bands. 
Instead of loading all probes at the same concentration as we did here, each probe concentration 
can be adjusted so that the end-point fluorescence intensity of each positive-control, in every 
color, is the same. This approach would significantly tighten the bands, making calling easier. 
The coding method can be further improved by switching to a single hybridization probe per 
target sequence. To maintain the coding in Table 4.1, each such probe would be present with 
corresponding color labels at the concentrations prescribed by the band-tightening optimization 
above. Making one sequence, aliquoting it, and labeling each aliquot with a corresponding color, 
is far less expensive than making multiple sequences each with its own color. As a result, the 
overall coding scheme is far cheaper to deploy in this second modality. Furthermore, it is far 
easier to fit just one hybridization probe to a target sequence, than two, three, or four. 
Under the coding scheme of Table 4.1, the maximal-multiplicity combination is 6323, which 
means all coded sequences are present. On the other hand, Table 4.1 has the tacit restriction that 
each sequence can have only 1x signal in any color. If we relax that restriction, we can add a 
sequence 1X00, which preserves the sequence counting property in the blue color. What is the 
minimal X, such that the new addition preserves the general structure of Table 4.2, keeps 




has to be the maximal previous cumulative multiplicity plus 1. Then any answer of 0-3 in the 
green digit is interpreted as before and means sequence 1400 is not present, while any answer of 
4-7 in green means 1400 is present and the full answer must have 1400 subtracted from it to 
obtain the rest of the present sequences using Table 4.2. 
Obviously, this system can be analogously expanded with additional sequences 1030 and 1004, 
for yellow and red, respectively. An analogy with Table 4.1 coding then suggests additional 
sequences 1404 and 1434. Iterating the same idea to the third tier will lead to further added 
sequences of 1800, 1060, 1008, 1808, and 1868. Thus, if just 3 tiers are used, the total number of 
sequences that are unambiguously identifiable in any combination, is 5x3=15, while the maximal-
multiplicity result would be 16-39-14-39, when all sequences are present. 
This expansion of the Table 4.1 coding offers theoretically infinite number of additional 
sequences that can be unambiguously identified in any combination. However, there are practical 
limitations on the assay, e.g. the ability to tell the difference between bands B and B+1 in the 
multiplicity call. Thus practically, there is a limited multiplicity bandwidth to be utilized by any 
coding scheme. Hence, the most efficient scheme is the one that uses that bandwidth most 
sparingly, so that M is maximized for a fixed Bmax. 
These ideas lead to the following third coding scheme. Each sequence has one probe with only 
one color. The sequences of each color are coded by the multiplicities of their probes. The first 
few sequences in blue are 1000, 2000, 4000, 8000. Similarly, the first few sequences in green are 
0100, 0200, 0400, 0800. This scheme is theoretically infinite as before, but it allows for more 
sequences per unit multiplicity bandwidth. For example, if we take the first 4 tiers, the number of 
unambiguously identifiable sequences in any combination are 4x4=16, while the “all-present” 
outcome is 15-15-15-15. This third scheme is better than the second scheme in terms of 
bandwidth density and practicability, but it does not possess the self-correcting qualities of the 
first and second schemes. We call this third scheme “binary” as the coded intensities correspond 
to single digits of different orders in binary counting. 
To test the binary scheme experimentally, we chose to use three sequences, Dengue Virus, HIV 
TPP, and HIV P17, in just one color (blue). The fluorescence signals from their probes in 
positive-control end-point PCR reactions were measured and used to calculate the respective 




non-null combinations of target occurrence were processed in a batch experiment using the 
same Masterplex mixture of primers and probes. The fluorescence signal of each case was plotted 
in a chromatogram (Figure 4.2). The multiplicity levels were assembled as the expected integer 
multiples of the 1x signal intensity, while their widths were calculated as the propagated 
uncertainty of the 1x measurement. That uncertainty was equated to the standard deviation of the 
fluorescence signals of the last five PCR cycles in saturation. 
 
 
Figure 4.2 Chromatogram of binary coded multiplex experiments in FAM 
 
The results in Figure 4.2 show a virtually perfect agreement between expectations and 
experiment. In every case, the result correctly decodes to the exact list of present sequences. 
Furthermore, the experimental set is exhaustive, as all theoretical combinations are accounted for 
and measured for the case of 1 color and 3 sequences. These results show proof of principle for 
the binary coding scheme. 
Conclusion 
The so-far described schemes all utilize standard fluorescence. However, fluorescence resonance 
energy transfer (FRET) can be used in conjunction with standard fluorescence to enlarge the set 




Taqman probes but have an orthogonal spectral output, because they emit one step further into 
the larger wavelengths. Thus if fluorescence interrogation of the sample is performed one color at 
a time, the signal from the standard probe will be shifted by one step but the signal from the 
FRET probe will be shifted by two steps. Then, detecting in each spectral band separately will 
produce independent signals. The same coding as described above can then be independently and 
simultaneously applied to the FRET probes. This should double the number of sequences that are 
unambiguously identifiable in any combination. So, for the third scheme used to the fourth tier, 
this means 4x4x2=32 sequences in the set. The tradeoff is that the analyzer systems would have 
to be FRET-capable. That limits usability with systems already embedded in practice, but the 
large gain in multiplexing would more than justify the feature in emerging systems. 
Our method of coding is a universal solution for systems limited by the requirement to fit 
multiple reporters within a certain bandwidth while avoiding overlap, crosstalk, and false 
positives. Thus the particular coding shown in Table 4.1 for four basis “colors” is just one of the 
possibilities under the general method. If the basis “color” set is expanded, e.g. by future 
fluorophores with tighter emission spectra, the described coding method is still fully applicable 
and will offer larger multiplexing factors. Thus the fundamental utility of the coding method will 
grow further with advances in probes. 
Also, while we discuss standard fluorophores as the reporter molecules, the same coding idea can 
be used with other systems, e.g. chemi-luminescence, or in fact any quantitative reporting where 
the output signal scales with the constituent signals of the same color, frequency, physical size, 
absorption band, etc. The cumulative signal does not have to be digital or scale linearly with 
number and intensity of constituent signals. For example, if the physical principle of 
measurement is absorption, the cumulative attenuation is a product of constituent attenuations 
while the concentrations are additive, due to the exponential nature of Beer-Lambert’s law. The 
logarithm of the cumulative attenuation will then scale linearly with constituent concentrations in 
each absorption band (the equivalent of color), so the same multiplexing method is still 
applicable. 
While our description focused on multiplexed end-point PCR for qualitative panels, the same 
method can be applied to certain types of qPCR. Digital PCR systems (e.g. BioRad’s digital 




numbers, and so are qPCR systems by output, but their actual mode of operation is end-point 
PCR [101, 102]. This means that our presented method can be immediately integrated into those 
systems and would drastically expand their productivity. 
Furthermore, we can confidently prophesy that the presented multiplexing method would work 
within traditional real-time PCR. First, the real-time data would be fully recorded as the PCR runs 
to completion. The end-point values would be decoded into the list of present sequences. Second, 
individual Ct’s can be gleaned in each color by detecting the maxima of the second derivative of 
the real-time curve in that color. Third, as a particular sequence gets amplified, fluorophores are 
released from its Taqman probes in the same ratios as the color multiplicities in the coding of that 
sequence. That is so because the amplification breaks up the same probe and thus has no bias 
among the colors for that sequence. Hence, e.g. under the second coding scheme, 1100 will have 
the same Ct in blue and green, while 1400 will have its green Ct precede its blue Ct by 2 cycles. 
This set of clues should be rich enough to decipher the identity and starting quantity of each 
present sequence. 
Finally, the applicability of the method is not limited to PCR or even biochemical assays. Any 
qualitative test producing a fixed amount of signal that is independent of the starting amount of 
the test’s target, is subject to the same mechanic and thus can benefit from this multiplexing 
method. If there is a “spectral” dimension to the physical basis of the test, the concept of “color” 
would apply, and thus the presented mathematical apparatus can be engaged to full force. If there 
is no “spectral” dimension, single-color multiplexing is still applicable, e.g. using the binary 







C h a p t e r  5  
FLUORESCENCE IMMUNOASSAYS IN MICROFLUIDIC ELASTOMERIC CHIPS FOR 
PORTABLE DIAGNOSTICS OF MULTIPLE SCLEROSIS  
Summary 
Herein we experimentally explore the possibility of rapid diagnostics and frequent monitoring of 
multiple sclerosis by using microfluidics to detect MMP-9. We demonstrate detection with 
SNR>10 using high-throughput microfluidic elastomeric chips with inbuilt fluorescence 
sandwich immunoassays. Our research shows the limit of detection is at least as low as 65 nM. 
Our results establish feasibility and form a solid basis for future R&D in this biomedical 
application. 
Introduction 
Multiple sclerosis is a debilitating auto-immune disease that affects the function of the central 
nervous system (CNS). The patient’s own immune system targets oligodendrocytes cells that are 
responsible for the myelination of neural axons. The immune response critically damages 
oligodendrocytes, halting production of myelin and leading to the rapid demyelination and 
eventual disintegration of the axons. Ultimately, the affected neurons lose the ability to conduct 
electrical impulses [103]. 
Diagnosis of multiple sclerosis is done through characterization of the symptomatic response, 
which varies with each patient. More common symptoms, associated with the loss of neural 
function, include fatigue, numbness, spasticity, vision loss, and depression. Most patients fall into 
one of the four identified symptom motifs for multiple sclerosis: relapsing-remitting (RR), 




   
Figure 5.1 Multiple sclerosis symptom motifs 
 
Approximately 85% of multiple sclerosis patients are initially diagnosed as relapsing-remitting; 
characteristics of these patients include episodes of acute symptoms followed by remissions of 
partial to complete recovery. Within ten years of the initial diagnosis about 50% of RR patients 
go on to exhibit secondary-progressive multiple sclerosis, which is characterized by a steady 
increase in symptom intensity with brief periods of acute symptoms and recovery [104]. A 
smaller percentage of patients, diagnosed as primary-progressive, exhibit a steady increase in 
symptom intensity from the onset of the disease. However, a very small percentage of patients 
with multiple sclerosis demonstrate a progressive relapsing syndrome, wherein symptom intensity 
steadily increases along with intermittent periods of partial recovery. 
Currently, there is no definitive serological test for multiple sclerosis. However, recent research 
has demonstrated the existence of specific biological markers for multiple sclerosis, which 
include matrix metalloproteinase 9 (MMP-9), a gelatinase enzyme that has the ability to cleave 
myelin [105], and Galactocerebroside (GalC), a transmembrane glycoprotein in oligodendrocyte 
cells that is a known target for demyelinating antibody responses [106, 107]. Furthermore, these 
markers have a demonstrated presence in the blood stream, making them promising candidates 
for immunological testing. 
Herein we experimentally explore the possibility of rapid diagnostics and frequent monitoring of 
multiple sclerosis by using microfluidics to detect MMP-9. We demonstrate successful detection 
with signal to noise ration (SNR) greater than 10 using high-throughput microfluidic elastomeric 




detection is at least as low as 65 nM. Our results establish feasibility and form a solid basis for 
future R&D in this biomedical application. 
Materials and Methods 
A high-throughput immunoassay chip (Figure 5.2) [108] was used to perform the microfluidic 
immunoassays. Soft lithography was used to fabricate the chips in polydimethylsiloxane (PDMS), 
an organic elastomer. The PDMS chips were then mounted and bonded on SuperEpoxy SME 
glass slides from TeleChem International. 
   
Figure 5.2 Elastomeric microfluidic immunoassay chip. 
 
The immunoassays were carried out using human MMP-3, MMP-9 antigens, anti-MMP-9 
polyclonal antibodies, and monoclonal human anti-MMP-9 and anti-MMP-3 antibodies 
manufactured by R&D Systems. Subsequent immunoassays were performed with human GalC 
and anti-GalC antibodies provided by a collaborator. 
The MMP proteins were reconstituted with TCNB buffer solution containing 50 mM Tris buffer, 
10 mM CaCl2, 150 mM NaCl, and Brij 35 (a stabilizing detergent manufactured by VWR 
Scientific.) The reconstituted proteins were aliquot into single-use centrifuged tubes, and 
refrigerated at -27°C until needed. Furthermore, monoclonal human anti-MMP-9 and anti-MMP-
3 were tagged with a Dylight 547 protein fluorescence labeling kit from the Pierce Corporation. 
The antibodies were stabilized with pure PBS buffer from Irvine Scientific. 
The chip was controlled with a Fluidigm BOB3 pressure-flow controller and was interfaced to the 
user with the Fluidigm uChip software. Antigen and antibody solutions were gently vortexed 




the fluorophores was performed with a green light of 552 nm. Pictorial data was obtained using 
a Sony DFW-V500 Fire-i digital microscope camera. 
Results and Discussion 
We built a simple two-layer immunoassay, using a high-throughput microfluidic immunoassay 
chip designed by Kartalov et al [108], to illustrate a proof-of-concept of multiple sclerosis disease 
detection. A serum of MMP-9 was flowed through the coliseums of the fluidic chip and allowed 
to bond to the epoxide moieties on the glass bottom surface of the micro-channels in the flow 
layer (Figure 5.3).  
 
Figure 5.3 False-color fluorescence image of MMP-0 two-layer immunoassay 
After passivating the remaining epoxide sites with TRIS buffer, fluorescently- tagged monoclonal 
anti-MMP-9 antibodies were pumped throughout the coliseums. Subsequently, the coliseums 
were flushed with TRIS buffer to liberate and remove any free- floating antibodies. Finally, the 
microfluidic chip was illuminated with light of wavelength 547 nm, and the fluorescence 
emission was captured by a CCD (Figure 5.3). We inferred the presence of MMP-9 from the 
observed fluorescence signal. 
Controlled detection of MMP-9 was done using a sandwich immunoassay (Figure 5.4) for MMP-
9. First, polyclonal goat anti-human MMP-9 molecules were flowed through the coliseums and 
allowed to bond to the epoxide layer of the immunoassay chip. After passivating the remaining 




MMP-9) was flowed through the coliseums. The MMP-9 was captured by the polyclonal anti- 
MMP-9 antibodies. Finally, fluorescently tagged monoclonal anti-MMP-9 antibodies were 
flowed through to bind to the MMP-9. Fluorescence imaging confirmed the presence of MMP-9 
(Figure 5.5). Furthermore, fluorescence was observed only in coliseums that had exposure to 
MMP-9, attesting to the specificity of the sandwich immunoassay. 
 
Figure 5.4 Sandwich immunoassay built onto epoxide substrate. 
             
Figure 5.5 False-color fluorescence images of MMP-9 sandwich immunoassays 
Since only fully formed sandwich immunoassays have fluorescently tagged antibodies, the 
intensity of the fluorescence emission corresponds to the strength of the signal. In one assay, we 




the red mean of the noise was 9.224 with a standard deviation of 9.23. This resulted in a SNR 
of 24 to 1. In another assay, we observed a red mean of the signal to be 72.6 with a noise floor of 
7.01, resulting in a SNR of 10 to 1. Successful immunoassays consistently had signal to noise 
ratios of 10 to 1 or greater. 
In future tests, we will attempt to do a more thorough characterization of the detection of antigens 
at ultra-low concentration. Additionally, we will attempt a three-stage characterization of multiple 
sclerosis through the detection of MMP9, myelin oligodendrocyte glycoprotein (MOG), GalC in 
the patient blood serum. Finally, we plan on integrating the microfluidic immunoassay chip with 
an elastomeric blood filter and CCD image capture device to illustrate the feasibility of a hand-
held multiple sclerosis monitor. 
Conclusions 
We have demonstrated a proof-of-concept of multiple sclerosis disease detection through 
successful detection of the biomarker MMP-9. Furthermore, fluorescence detection of MMP-9 
yielded SNR in excess of 24 to 1, with a minimum SNR of 10 to 1. Subsequent testing has 




C h a p t e r  6  
IMMUNOAFFINITY CHROMATOGRAPHY IN ELASTOMERIC                
MICROFLUIDIC DEVICES 
Summary 
Immunoaffinity chromatography (IAC) is an important stage in sample-prep workflow in modern 
biotechnology. Herein we report on a microfluidic device that performs IAC. The demonstrated 
performance of the device is a proof-of-principle for microfluidic miniaturization of IAC, and 
thus is an important step towards integrated disposable devices performing DNA- and RNA- 
based diagnostics. 
Introduction 
Recent advances in microfluidic and microelectromechanical systems (MEMS) technology has 
allowed for the fabrication of miniaturized disease detectors. One mode of pathogen detection is 
through the use of miniaturized polymerase chain reactors (PCR) [109]. PCR is a quick and 
inexpensive process that allows for amplification of a given nucleotide sequence (Figure 6.1). 
DNA polymerase is utilized to copy a DNA template in successive cycles of amplification. The 
singular advantage of PCR is that is can be carried out exclusively in vitro.  
A similar technique called real-time polymerase chain reaction (RT-PCR) allows for DNA 
quantification [111]. In RT-PCR, the fluorescence of an intercalating dye is measured after each 





          
Figure 6.1 Generic scheme of polymerase chain reaction [110]. 
The relative number of DNA copies in a sample can then be interpolated by comparison to 
standard DNA dilution curves (Figure 6.2).  
The speed and accuracy of RT-PCR makes it attractive for point-of-care diagnostics. However, to 
increase PCR amplification yield, it is necessary to start with a concentrated DNA serum. This 
can be accomplished by taking advantage of the lock-and-key interactions of antibodies and 
antigens [112-115]. In a process called IAC, biological mixtures are separated and concentrated. 
Using IAC methods, it is possible to sift through an environment sample to find a molecule of 





              
Figure 6.2 RT-PCR amplification curves for various concentrations of sample                 
DNA (example). 
 
Microfluidics provides a suitable platform for IAC since it allows for manipulation of minute 
quantities of fluids. By replicating column affinity chromatography (Figure 6.3) in a microfluidic 
chip, the quantities of reagents and samples used can be minimized. This results in a significant 
cost and time reduction for the immunoassay. Here, we present a proof-of-concept microfluidic 
immunoaffinity chromatography device that can be eventually used in conjunction with Parylene-
based RT-PCR reactor. Eventually, this conglomerate system will form the basis of a hand-held 
detector for SARS. 
 





Materials and Methods 
The fluidic chip was first designed on a computer using SolidWorks, a three-dimensional 
modeling tool. This model was then used to produce an aluminum replica mold for the chip. 
Sylgard Dow-Corning 184 Elastomer—generic name, polydimethylsiloxane (PDMS)—was used 
to fabricate the fluidic chip. A Keyence Hybrid Mixer HM501 was used to prepare the elastomer 
in a 10:1 ratio of base to curing agent. A layer of PDMS was poured over the aluminum replica 
mold, degassed in a vacuum chamber, and thermally cured at 70°C for 60 minutes. Afterwards, 
the chip was cropped and cleaned with dilute 2-propanol. 
Two through-holes were made for the input and output ports using a modified drill press. A 23 
gauge aluminum cut tube, Type 304 manufactured by New England Small Tube, of external 
diameter about 647 micron was inserted into the inlet and into the exhaust. The affinity 
chromatography chip was then mounted on a sterile glass slide, and clamped with binder clips 
(Figure 6.4). The clamps and cut tubes were bonded to the surface of the PDMS using epoxy. The 
inlet and exhaust tubes were fitted with Tygon Microbore tubing manufactured by Cole-Parmer. 
The input port of the chip was then mated to a 1cc syringe using a 23-gauge lure stub adapter. 
Reagent flow was driven using a programmed Pico Plus 11 syringe pump manufactured by 
Harvard Apparatus. 
 
Figure 6.4 IAC chip clamped with binder clips. 
 
The immunoaffinity chromatography was modeled on the procedure of the Seize Primary 
Immunoprecipitation Kit (Catalog Number 45335) manufactured by the PIERCE Corporation. 
Off-chip validation of the RT-PCR was also performed using this commercially available affinity 
chromatography kit. The agarose-sepharose beads provided in the kit were functionalized and 
bonded with antibodies specific to the M13 virus. During the on-chip chromatography, the beads 




immunoprecipitation buffer, and elution buffers were flowed through the channel at rates not 
exceeding 11 µL/min, and virus capture and elution took place throughout the inlet channel. After 
the chromatography was performed, the samples were analyzed using a Stratagene MX3500P 
RT-PCR machine. Further analysis was performed using a Fuji laser-based gel electrophoresis 
imager. 
Results and Discussion 
The primary device investigated was a simple fluidic filter fabricated in PDMS. This fluidic 
device consists of a 50-micron wide filter section sandwiched between two 650 micron wide inlet 
and exhaust channels (Figure 6.5). The dimension of the filter section was chosen in order to 
obfuscate the flow-though of immunoaffinity beads on which the chromatography occurs. A 
simple statistical analysis of bead sizes showed that mean and median bead size was 
approximately 80 micron. The device has a 2:1 height to width ratio, which was necessary to 
prevent the walls of channel from collapsing. The PDMS chip was bonded and clamped to a glass 
slide. The input port was mated to a syringe pump to drive reagent flow, while the exhaust port 
was attached to a centrifuge tube to collect the flow through. 
 
Figure 6.5 Top and side views of IAC fluidic chip layout 
 
A M13 bacteriophage virus was used to test the biology and chemistry of the chromatography 
device. First, M13 antibodies were bonded to agarose-sepharose beads. These beads were then 
flowed and sequestered in the inlet channel of the device. A simulated sample serum of M13 was 
flowed through the channel. The M13 antibodies captured the virus of interest though highly 




through immunoprecipitation buffer, the captured virus was liberated from the bead matrix by 
flowing elution buffers. 
All the flow-throughs were saved and analyzed using a commercial off-chip RT-PCR device. A 
gel-electrophoresis was run to confirm that the fluorescence was indeed from the product of 
interest, and not from spurious DNA (like primer-dimers). By comparing the fluorescence of the 
samples with the fluorescence of several standard M13 concentrations, the relative quantity of 
eluted M13 virus was determined (Figure 6.6). The elution (Elution 1, Figure 6.6) on-chip IAC 
procedure was able to provide a -100x concentration of the sample M13 serum (M13 F.T., Figure 
6.6). Though the on-chip IAC ended up diluting the virus serum, it did perform an order of 
magnitude better than an off-chip IAC procedure using a commercially available kit. 
 
Figure 6.6 Graphs of cycles till threshold fluorescence vs. concentration for on-chip IAC02.  
 
Using the fluorescence data from the standard curve, it was determined that approximately 2000 
viruses were eluted. This corresponded almost exactly to the estimated number of antibody 
bonding sites in the channel of the IAC chip. The insufficient number of bonding sites may 
explain why the IAC device was only able to achieve negative concentrations. (In the future, it 
may be necessary to redesign the inlet channel in order to accommodate more agarose beads— 




flow-throughs confirmed that the correct M13 genome was amplified. Finally, two control 
chromatography experiments were performed: an IAC with beads with no antibodies attached, 
and an IAC with no beads at all. There was an absence of virus in the elutions of both these 
controls. This confirmed that immunoaffinity chromatography had indeed taken place in our 
original experiment. 
In the future, we plan to investigate a higher-throughput fluidic chip that will allow for faster 
affinity chromatography. This device will employ multiple filter sections in a completely 
embedded channel in PDMS (Figure 6.7). Reducing the fluidic resistance of the filter and 
providing a larger surface area for virus capture will allow the device to concentrate the sample 
quicker. Furthermore, we also plan on devising methods to pack beads more tightly in the inlet 
channels of the first generation of chromatography chips—by increasing bead input flow rates, or 
by widening the inlet through-holes—in order to provide more binding sites for the M13 virus. 
     
Figure 6.7 High-throughput fluidic channel. 
 
Finally, we plan on optimizing the RT-PCR process in order to get data to better quantify the 
performance of our chromatography technology. 
Conclusion 
Immunoaffinity devices will become increasingly important in coming years, as they provide the 
possibility of portable pathogen detection. Specifically, microfluidic quantitative real-time 




diseases including SARS coronavirus, the virus responsible for the severe acute respiratory 
syndrome (SARS). Our device provides a proof-of-concept for integrated on-chip IAC that can be 





C h a p t e r  7  
MICROFLUIDIC EVAPORATIVE COOLING 
Summary 
Localized evaporative cooling in fluidic channels provides an elegant and low-cost solution to the 
problem of cooling electronics, optics and chemical reactions. By optimizing the geometry of a 
Y-junction and the gas/evaporant ratios, we found that the optimal refrigeration took place in a 10 
degree Y-junction when using ethyl ether as the evaporant. Maximum temperature drops were 
measured when gas inlet pressures were between 21 psi and 36 psi. The evaporation of ethyl ether 
also enabled temperatures as low as -20°C to be sustained for several minutes. These findings 
prove principle for evaporative cooling in microfluidic systems. 
Introduction 
Miniaturization of components has been the defining trend in the world of electronics and optics 
for the past 50 years. Moore’s law predicts a doubling of transistors density in approximately 
every 18 months [115], and transistor resolution is now well below 100nm [116]. With this rapid 
increase in transistor density, the fundamental problem of heat dissipation places ultimate 
limitations on processing power and device speed. Attention to energy consumption and heat 
dissipation is of paramount importance [117] when designing new electronic and optical 
architectures. So far, heat dissipation has been addressed in a variety of ways, from “sleep” 
transistors [118] to on-chip micro-refrigeration [119]. 
Besides electronics, there are many fields in need for miniaturized refridgeration: optical and 
microwave detector cooling, polymerase chain reactor cycling, and thermal stabilization of high 
power telecommunications lasers. Temperature control has also become very important in 
ensuring the precise control of thermally sensitive reactions within the framework of 
microfabricated chemical “laboratories” in which sub-nanoliter volumes of reagents are reacted 
on microfluidic chips. 
Herein we present a unique solution to the problem of heat dissipation: localized cooling through 




can be achieved through the endothermic mixing of compressed gas with an evaporating liquid 
[120]. Herein we demonstrate that evaporative cooling works in microfluidic devices as well. 
Materials and Methods 
The fluidic channels were first designed on a computer using SolidWorks, a three-dimensional 
modeling tool. These models were then converted to a usable file format using SolidScape’s 
ModelWorks software. Wax molds of the fluidic channels were created using a SolidScape T66 
wax printer. The wax molds were then chemically cured (to remove unwanted build wax) with 
Petroferm Bioact VS-0 Precision Cleaner, and thermally cured by overnight heating at 37°C. 
Sylgard Dow-Corning 184 Polydimethalsiloxane (PDMS) elastomer and curing agent were mixed 
in a 10:1 ratio using a Keyence Hybrid Mixer HM501 to fabricate the fluidic channels. The 
PDMS was then cured in a three-step process. First, a 0.3 mm thick initial layer of elastomer was 
degassed in a vacuum chamber for 10 minutes and thermally cured at 80°C for 8 minutes. Next, a 
second, thin layer of uncured PDMS was poured on top of the first layer. The wax junction-mold 
was then placed on the second layer of PDMS. Finally, a 3 mm thick layer of PDMS was poured 
on top of the wax mold. The setup was finally pumped down in a vacuum chamber for 25 minutes 
to degas the elastomer and then heated at 54°C for 4 hours to thermally cure the PDMS. 
The PDMS blocks were then cropped and de-waxed (by heating to 90°C for 15 min). Acetone 
was rinsed through the fluidic channels to remove residual build wax. The fluidic chips were then 
attached to a refrigerant and N2 gas inlets. An Omega Precision fine wire, K-type thermocouple 
was inserted into the outlet of the fluidic channel. The thermocouple had a diameter of 0.125 
mm—small enough not to interfere with the outlet of refrigerant and gas. The thermocouple was 
attached to an Omega iSeries i/32 temperature controller that logged the temperature in the 
junction at a rate of approximately 3 Hz. Temperature measurements were made using this 
controller interfaced to a computer via serial port and Microsoft HyperTerminal. The inlet 
pressures of the refrigerant and the gas were monitored using TIF Instruments digital pressure 
meters. 
Results and Discussion 




and the other for the gas. Evaporation occurs throughout the outlet channel. In our experiments, 
each channel has a length of 6.5 mm and a diameter of 0.650 mm. The angle of the Y-junction 
was varied between 10 degrees and 180 degrees, and the cooling effect was characterized as a 
function of angle, inlet gas pressure (N2) and type of refrigerant. We successfully characterized 
such evaporative cooling using ethyl ether, acetone, ethyl alcohol and isopropyl alcohol. 
       
Figure 7.1 Y-Junction cooler geometry. 
Preliminary characterization of the channels indicated that the lowest refrigeration temperatures 
were achieved by evaporating ethyl ether. We believed that this was due to the very low specific 
heat and boiling point of ethyl ether—enabling rapid vaporization. Ethyl ether pressure was 1.2 
psi, while the N2 inlet pressures were in excess of 20 psi. Refrigeration rates recorded for the 
vaporization of ethyl ether were approximately 40°C/s. The evaporation of ethyl ether also 
enabled temperatures as low as -20°C to be sustained for several minutes (Figure 7.2). Prolonged 




   
Figure 7.2 Temperature drop versus time for four refrigerants. The gas inlet pressure for the 
isopropyl alcohol, ethyl alcohol, and acetone graphs was 20psi. The gas inlet 
pressure for the ethyl ether experiment was 21psi. 
 
The rates of temperature decrease in the mixing channel were also characterized with respect to 
the gas inlet pressures. We incremented gas inlet pressures from 0 psi to 36 psi in steps of 3 psi, 
and found that there was a positive relationship between the gas inlet pressure and the 
refrigeration rate. However, we noted that inlet pressures in excess of 21 psi did not significantly 
increase the cooling effect further (Figure 7.3). We suspected that such increases in the gas inlet 
pressure created back-pressure within the inlet channels, and a corresponding disruption in the 





Figure 7.3 Graph of minimal attainable temperature versus time for two channels impinging 
at 10 degrees. Legend indicates inlet gas pressures in psi. 
 
We also characterized Y-junction geometries with respect to angle between the channels. We 
found that the slowest refrigeration occurs when the angle between the channels forming the Y-
branch is large (180 degrees), and the refrigerant supply and nitrogen evaporation gas sources 
point at each other. Conversely, the most efficient cooling was measured when the angle between 
these two supply channels was 10 degree Y-junction. We think this was due to the fact that in 
smaller angles, flow congestion at the junction can be minimized. Smaller angles allow the 
vaporized refrigerant and heat to leave the system faster. Furthermore, larger angles exhibit 
significant back-pressure problems at pressures in excess of 15 psi (Figure 7.4). Back-pressure 
prevents proper refrigerant flow, thereby dampening the cooling effect. This was most clearly 
demonstrated in a test for the 180 degree junction with gas inlet at 25 psi and ethyl ether inlet at 





Figure 7.4 Minimum attainable temperature (Centigrade, vertical axis) drop versus time 
with respect to junction angle of channel (degrees, horizontal axis). The gas inlet 
pressure for the 10 degree channel was 21psi. For all other channels, the gas inlet 
pressure was 20psi. 
 
We also investigated the increase of the size of the outlet channel in hopes of promoting the 
expansion associated with evaporation of the refrigerant. However, we found that widening the 
outlet channel to a diameter of 2 mm did not result in faster refrigeration. 
A copper heat sink was also embedded into a fluidic chip. In this chip, it was observed that the 
cooling effect in the Y-junction channel resulted in a cooling effect in a second channel. The 
copper heat sink acted as a thermal bridge between the two channels. With this model, it was 
possible to demonstrate the cooling of an external heat source. This experiment confirmed that it 
is possible to apply the evaporative coolers for electronic and optical cooling purposes. 
Ultimately, we hope to develop self-sustaining, closed systems in which the refrigerant is 
conserved. One possibility for refrigerant conservation would employ a selective, organic 
membrane at the output channel. Furthermore, in order to provide an applicable solution for the 
cooling of electronics, we plan on integrating microfluidic cooling systems into silicon. 
Conclusions 
Localized evaporative cooling in fluidic channels provides an elegant and low-cost solution to the 




Y-junction and the gas/evaporant ratios [120], we found that the optimal refrigeration took 
place in a 10 degree Y-junction when using ethyl ether as the evaporant. Maximum temperature 
drops were measured when gas inlet pressures were between 21 psi and 36 psi. The evaporation 
of ethyl ether also enabled temperatures as low as -20°C to be sustained for several minutes. 






C h a p t e r  8  
CONCLUSIONS AND NEW DIRECTIONS 
The content of this thesis is divided into two broad categories: microfluidic devices for biological 
measurement and biological techniques. The microfluidic tools described in this thesis each 
perform a specific task (e.g. concentrating nucleic acids or performing a polymerase chain 
reaction). However, these devices can be combined and cascaded in various combinations to 
perform a variety of tasks in a miniaturized laboratory footprint. As such, these individual devices 
are akin to tools in a microfluidic tool kit. We will briefly describe some of the ways these simple 
tools can be combined to make more complex instrumentation. 
We will also describe some of the applications and extensions of the supercolor coding methods 
described in the thesis. These coding methods can be used in real-world scenarios, and we will 
show the performance of such assays in a clinical laboratory setting. Furthermore, we will 
describe new directions for nucleic acid probe designs that might bridge the information density 
gap between PCR and sequencing. 
Modular Fluidics 
Modular microfluidic components have been speculated before [121-123], though these 
components are often integrated on a single microfluidic substrate [124]. This diminishes the 
utility of microfluidic breadboarding, however, forcing integration to take place pre-fabrication 
rather than post-fabrication. Yet, post-fabrication breadboarding can be realized if the PDMS-
PDMS interconnects are properly gasketed to pressure gradients and to limit fluidic losses [125-
127]. 
The various sensors and devices described in this thesis can be connected and daisy-chained to 
form more complex, integrated microfluidic systems. For example, the immunoaffinity 
chromatography chip can be mated upstream of the PCB-based PCR device to create the 
foundation for a sample-to-answer PCR instrument. Since all the microfluidic devices described 
in the body of thesis have been designed to be coupled, a variety of more complex micro-




For instance, the platinum heating elements can be coupled with the evaporative coolers to 
form a miniature temperature management system to control chemical reaction rates. This system 
might be used as substrate for nucleic acid amplification, or a substrate for the careful generation 
of particular chemical products. Future work will incorporate the heaters, coolers, and DNA 
extraction devices to form the basis for might ultimately be a low-cost, portable disease 
diagnostic. 
Applications of Multiplexing PCR in Real-World Scenarios 
In this thesis, we described super-color coding methods for the polymerase chain reaction using 
synthetic nucleic acid targets. One practical application of this technique is the detection of 
infectious diseases in clinical samples. In order to demonstrate the efficacy of the super-color 
coding technique in clinical samples, we designed a single color, seven-target PCR assay for 
respiratory illnesses. This panel was designed to look at targets for strains of Influenza (InfA and 
InfB), Respiratory Syncytial Virus (RsvA and RsvB), Human metapneumo virus (Hmpv), Human 
rhino virus (Hrv), parainfluenza (PIV-3); these sequences are listed in Appendix B Tables 1-7. 
This assay was multiplexed using the binary coding technique described in chapter four. Thus, the 
reporters for InfA, InfB, RsvA, etc. were coded with a 1x, 2x, 4x, etc. intensity. Clinical aspirate 
samples from patients in the Dartmouth Hitchcock Medical Center were spiked with synthetic 
targets corresponding to 100 nM concentrations of Influenza A, Influenza B, and Respiratory 
Syncytial Virus. The blinded, spiked clinical aspirate samples from hospital patients were 
processed using standard hospital sample preparatory protocols to extract nucleic acids. The 
resulting sample serum, containing a possible combination of InfA, InfB, and RsvA, was 
processed in a PCR detection protocol using the seven-target assay. We found that the multiplex 
coding technique was able to successfully distinguish arbitrary combinations of the infectious 




       
Figure 8.1  Chromatogram for intensity-coded multiplexed PCR in clinical samples spiked 
with respiratory viruses. The bands represent the multiplexed counts, and the bar 
and stem data points represent the data points with measurement uncertainty.  
 
We also applied the binary coding technique to a set of single-plex PCR assays for regulatory 
genes GusB, B2M, and GapDh. The primer and probe sets were titrated in a 1x, 2x, and 4x 
fashion, respectively, to generate a single-color, triplex panel. This panel was tested on human 
genomic samples containing combinations of the three genes at a CLIA laboratory facility in 
Irvine, CA (ResearchDx). We again demonstrated that the supercolor coding technique was able 





Figure 8.2 Chromatogram for intensity-coded multiplexed PCR in human genomic samples. 
The bands represent the multiplex counts, and the bar and stem data points 
represent the data points with measurement uncertainty. 
 
These results suggest that the supercolor coding techniques can be used in real-world scenarios to 
identify and eventually quantify, nucleic acid targets in various combinations. We aim to collect 
data and explore the use of this technique in a variety of clinical samples in the near future. This 
will likely pave the way for the use of midplex PCR (6 - 40 targets per reaction) for clinical 
diagnosis of disease as well as the identification of particular genomic markers. While this does 
not approach the information-rich data sets generated by whole genome sequencing, it does 
significantly improve the data density of the more widely-used PCR. 
Codes in DNA 
Another application of supercolor PCR multiplexing is for the encryption and decryption of 
digital codes into nucleic acids. Cryptographic techniques are used for the encoding and decoding 
of information that needs to be hidden from all possible recipients except for the intended target. 
However, efficient codes must strike a balance between complexity of coding and density of 
information. Furthermore, the interpretation of these codes should be done in a way that a reader 
(intended recipient) can decode the information in an unambiguous fashion. Elegant codes can 
achieve this with one-to-one mapping of information to cryptogram. For instance, a one-to-one 




requires a base-26 code for the mapping. 
However, there is a less complex, but less spatially compact way of replicating this type of code. 
Binary values of a predetermined length can be used to code for letters and symbols. For instance, 
the English language ASIC lookup table maps a hexadecimal (effectively binary) code to every 
character of the language. This allows for the coding of letters in a fashion that can be understood 
by machines. 
For instance, consider the set of n-unique organisms (such as bacteriophages, bacteria, or other 
viruses), where each organism represents a “bit” of the message. If we consider a set of n=20, and 
if organisms 1, 3, 6, and 19 are present, the code would be read as: 01000 00000 00001 00101 
(Table 8.1).  
Table 8.1 Examples of organism-based coding for a 20-bit protocol. 
Organisms Present Interpretation 
1,2,3 00000 00000 00000 00111 
1,2,5 00000 00000 00000 10011 
2,6,12 00000 00010 00001 00010 
1,3,6,19 01000 00000 00001 00101 
 
In order to decode the message, the recipient would only need to run a multiplexed PCR reaction 
containing the message contents, which allows for a fast decoding of the message contents. Since 
the state-of-the-art in PCR allows for the simultaneous measurement of 4 - 6 targets, supercolor-
coded PCR is an ideal candidate to implement this coding technique. We are currently exploring 
the feasibility of these encryption techniques in the coming months. 
Transportation of the Message 
Furthermore, several techniques could be used for the transportation of the message contents. 
Nucleic acid cryptograms can be easily transported in a variety of organic desiccants that preserve 
the bond structures while preventing contamination from external environment. One such 
embodiment is the inclusion of nucleic acid cryptograms in saccharide-based desiccant. For 
instance, the cryptograms can be preserved inside of sucrose packages for transportation. In 




if the need should arise. The message contents can be easily and safely digested by human and 
animal consumption. Furthermore, the message contents can be obfuscated, destroyed, and 
disposed of by dissolving the saccharide package in a solution including but not limited to saliva, 
water, urine, soda, ethanol, and alcoholic beverages. This package form factor is particularly 
advantageous, since it is very similar to hard candy. This allows for the package to be physically 
transported from the creator to the intended recipient without arousing suspicion. 
When the message contents need to be read, the saccharide package would be dissolved in a 
known solution that is conduce to nucleic acid stability. An electric field can be applied to extract 
and concentrate the nucleic acid cryptogram. Simple sequencing can be used to determine the 
content of the message. 
Providing a natural environment for each “bit” of the message would likely preserve the contents 
for an appreciable amount of time. For instance, in an n-bit code each organism can be stored in a 
host such as a small rodent or mammal. In order to decode the message, the recipient would only 
need to draw the blood of the animal and run a PCR reaction. The message host provides the ideal 
conditions to preserve the message, while having the added benefit of degrading the contents of 
the message for prolonged time scales (i.e. the host will die due to infection). In fact, the SNP 
sequences from the host can be used to authenticate the information that is encrypted. 
Alternatively, hosts can be intentionally tagged with benign organisms for identification 
purposes. For instance, a predetermined set of non-lethal bacteria or viruses can be used to infect 
a human host. When the human host is required to provide authentication of their identity, a drop 
of blood can be extracted from them. The PCR analysis run on the blood would confirm their 
identity. Because of the specificity of the PCR reaction, only the intended authenticator would 
know how to interpret the nucleic acid contents of the blood sample. Furthermore, this has the 
additional benefit of obfuscating the contents of the message (i.e. blood sample), since the blood 
will contain native host DNA as well as the DNA of any parasitic and symbiotic organisms. 
In another variation, organisms can be used to transfect the host with particular nucleic acid 
targets. These targets would code for unique proteins that would be expressed in the blood. In 
order to read the message contents, the blood contents would only need to be processed in an 
immunoassay such as an ELISA. The specificity of the antibody-protein bond would allow the 




Extension to Sequencing 
Eventually, these coding techniques can also be realized using DNA sequencing, instead of PCR. 
For example, consider a scheme wherein the A-T 2mers code for the digit 0 and A-A and T-T 
2mers code for the digit 1. In this case, a reading of either A-T or T-A is interpreted as a 0, while 
the reading of either A-A or T-T is interpreted as a 1. Since DNA is readily stabilized by its 
complementary strand, this allows for a natural redundancy in the message contents. In this 
coding scheme, the reading frame is determined by the binary spacing of the intervening G’s and 
C’s. For instance, consider the sequence following sequence: 
5’ATGGGGGGGGATGGGGATGGATG3’ 3’TACCCCCCCCTACCCCTACCTAC5’ 
Here, the message is read starting at the 5’ end of the bottom strand. This is due to the fact that 
the G-C spacing increases as the frame shifts downstream (to the 3’ end). The coding base pairs 
(A’s and T’s) can be tagged with variety of reporters including but not limited to heavy metal 
ionic tags, fluorescent markers, quantum dots, quenchers, hydronium (ph-based) markers, and 
radioactive tags. The message contents are read by sequencing the entire DNA strand. The 
spacing between the reporters allows the reader to determine the location of the message he is 
reading, while the tags themselves denote how the content is to be interpreted. 
Novel Nucleic Acid Probes 
Our investigations into multiplexed PCR sequed into a survey of the different part of nucleic acid 
reporters. Nucleic acid targets are discriminated using one of several techniques including 
fluorescence intensity measurement (using TaqMan probes, FRET probes, or intercalating dyes), 
length discrimination (using gel electrophoresis, melt curve analysis, etc), or chromatography 
(haptin-based nucleic acid capture, etc.). Whereas, we described PCR combinatorial coding with 
using traditional probe chemistries, these codes are extensible to novel probes as well. 
For example, individual PCR primers can be ligated with chromaphores. Consider a scheme 
wherein the chromaphore on one primer is a fluorophore and the chromaphore on its 
complementary primer is a matched quencher. As a PCR reaction, specific to these two primers, 
proceeds to completion, the observed fluorescence will decrease. This is because a correctly 









We can design the forward (FWD) and rewind (RWD) primers such that a quencher and 
fluorophore are ligated to the 5’ of each primer respectively: 
FWD Primer /Quencher/5’ATGGGGGGGGGGGGGGGGAT3’ 
RWD Primer 3’CCCCCCCTACCCCTACCTAC5’/Fluorphore/ 
 
If the primers are selected in appropriate concentrations to limit unbound quenching, before the 
first cycle of PCR reaction is run, there will be a total intensity of X. During the first cycle of the 
PCR, this intensity level will be unchanged, as there will be no DNA target present that 
incorporated both a fluorophore and a quencher. As the cycles progress, on average, the total 
fluorescent signal will decrease by a factor of 2 per cycle. Therefore, the fluorescent intensity at 
the end of cycle two will be X/2. This is due to the fact that the persistence length of DNA target 
is such that the fluorophore on the anti-sense strand is efficiently quenched by the quencher on 
the sense strand. This attenuation of the fluorescent signal will continue till the supply of primers 
for that target have been exhausted. In this way, a “dark-field” measurement for the DNA target 
can be obtained by looking at the intensity of fluorescence after each cycle. Schematically, the 




/Q/5’ATGGGGGGGGGGGGGGGGAT3’ -> Extension Cycle One Annealing 
/Q/5’ATGGGGGGGGGGGGGGGGATGGGGGGGGAAGGGGGGATGGGGGGGGATGGGGATGGATG3’ 
Extension <- 3’CCCCCCCTACCCCTACCTAC5’/F/ 
3’TACCCCCCCCCCCCCCCCTACCCCCCCCTTCCCCCCTACCCCCCCCTACCCCTACCTAC5’/F/ 












Figure 8.3 Chromaphore-tagged primers for DNA synthesis over subsequent cycles. As the 
polymerase chain reaction proceeds over consecutive cycles (c)-(g), the two 
chromaphores are brought into close proximity (f), reducing the overall 
fluorescent signature. 
 
Furthermore, by carefully observing this PCR reaction at both the denaturation and the annealing 
stages (Figure 8.4), we can get a cycle-by-cycle normalization. This chopper stabilization is 
possible because the original (cycle zero) fluorescence signature is fully recovered when the 
strands are totally unbinded at denaturation temperatures. At these temperatures, the coupling 
between the quencher the fluorophore is lost, allowing for a self-normalization of the PCR 
fluorescence signature. In contrast, the measurements made during annealing track the actual 





Figure 8.4 Temperature and light-intensity measurement schedule for tagged-primer PCR. 
Fluorometry is performed at both the denature and annealing temperatures. 
 
Initial proof-of-principle of the primer-tagged technique was performed using synthetic nucleic 
acid targets chosen from the Human Immunodeficiency Virus 1 (HIV-1) TPP gene. We observed 
that this novel probe technique was successfully able to report on the progress of PCR (Figure 
8.5), over a large dynamic range of initial TPP target concentrations. Wee found that the primer-
tagged assay was equally sensitive and specific as the traditional HIV-1 TPP assay (described in 
chapter four). 
Furthermore, we noticed that nucleic acid targets of varying lengths, for a giving tagged-primer 
set, exhibited characteristic fluorescence signatures. By testing this technique on HIV TPP targets 
ranging from 40bp to 190bp, we found that the extent of the endpoint quenched signature varied 
inversely with the length. Interestingly, the initial data did not fit the FRET fluorescence model, 
and was instead consistent with electronic conduction models suggested by other researchers 
[136-143]. 
Furthermore, initial observations indicate that a single base pair change affects the probability 
that a particular electron diffuses from the donor to the acceptor. For example, a single base-pair 




indicates that this effect is base-pair dependent (i.e. an A-T match, a T-T mismatch, a G-T 
mismatch, and a C-T mismatch all generate unique signatures). We suspect that any point 
mutations affect the electron forward conduction probability, and hence the quenched signal. This 
implies that this novel probe technique has the capability of being even more sensitive than 
traditional nucleic acid assays for detecting single point mutations. This will be the subject of 





Figure 8.5 Successful primer-tagged PCR detection of HIV TPP targets. Initial experiments 
show the qPCR detection of 80bp HIV TPP targets at varying concentrations 






Higher Density Coding 
Part of the novelty of tagged-primer PCR is that chromaphores are permanently ligated onto the 
amplified strands. This allows for more sophisticated coding schemes. For example, consider a 
scheme where the ordering of identifying color distinguishes a particular sequence. Each nucleic 
acid target can have tagged-primer pairs of varying length that are selectively incorporated into 
the template strands as a function of the annealing temperature (Figure 8.6). By carefully 
controlling this temperature zone, the kinetics of the PCR reaction can be tailored to allow for the 
binding of a particular primer/probe with greater probability at a given cycle. For instance, longer 
primers can be exhausted first by initially having an annealing temperature that is higher than the 
melt temperature of the competitive smaller primers. As such, the kinetics of a PCR reaction, as 
well as the dynamics for reporting on that reaction, can be controlled by temperature alone. 
 
Figure 8.6 Higher density combinatorial coding of nucleic acid targets using tagged-primers. 
  
This allows for the coding of PCR reactions using novel 2-dimensional labels of wavelength-
temperature pairs. In its simplest iteration, the maximum occupancy for a specific temperature 
zone is four (one target, per color, per temperature step). In the case of a four color instrument, 
we can code for up to 16 targets in a single well (Table 8.2). As the PCR reaction proceeds, we 
look for changes in fluorescence in each color channel. If the change in a particular color crosses 




Table 8.2 Mapping of wavelength-temperature pairs to code for particular sequences. 
Color\Temperature T1 T2 T3 T4 
B Seq01 Seq05 Seq09 Seq13 
G Seq02 Seq06 Seq10 Seq14 
Y Seq03 Seq07 Seq11 Seq15 
R Seq04 Seq08 Seq12 Seq16 
 
Final Thoughts 
The material reported in this thesis represents an initial foray into the use of engineering tools and 
techniques for biological measurement. While this has yielded encouraging initial results, there is 
still much to be explored. For example, more sophisticated microfluidic tools will allow for novel 
measurements on a variety of biochemical phenomena. Furthermore, analysis strategies borrowed 
from information theory and combinatorics will allow for more detailed analysis of these 
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A p p e n d i x  A  
PCR REACTION PROTOCOLS 
All PCR reactions were performed on a Roche 480 LightCycler instrument (Roche 
Applied Science, Penzberg, Germany). The PCR cycling reaction was run for 45 cycles, 
with a 60 sec hot-start at 95°C. The cycling conditions were: denaturation for 45 sec at 
95°C, annealing for 50 sec at 65°C, and extension for 60 sec at 70°C. Each experiment 
was run in quintuplicate, with a reaction volume of 15µL. Fluoresence measurements in 
483nm-533nm (FAM), 523nm-568nm (Cy3), 558nm-610nm (ROX), and 615nm-670nm 
(Cy5) were first taken after the hot-start, and again taken at the end of 45 thermal cycles. 
The change in fluorescence intensity between these two measurements, for each instance 
of an experiment, determined the fluorescent signal. 
Positive control experiments were performed to determine base-line fluorescence levels 
for each target and set of probes. Only targets with their associated probes were cycled in 
experiments 1, 3, 5, 7, 9, tabulated in Tables A.9, A.11, A.13, A.15, A.17, A.19. These 
were positive-control experiments that provided baseline fluorescence intensity for each 
oligo target. The change in fluorescence intensity, in each color, was used to assemble the 
expected cumulative signal levels in the chromatograms in Figure 4.1. The combinatorial 
superposition of fluorescence levels, in each independent wavelength channel, 
determined the actual bands for each count. Experiments 2, 4, 6, 8, 10, measured the 
extent of cross-talk. 
Experiments 11, 12, 13, 14, tabulated in Tables A.11 – A.14, were multiplex coding 
experiments. Their changes of fluorescence intensity in each color was presented by the 
black circles in the chromatograms of Figure 4.1. 
Experiments 23 – 27, tabulated in Tables A.23 – A.29, were binary-coded multiplex 
experiments in the FAM channel. The change in fluorescence intensity at the end of the 
saturated PCR experiment was presented by the black circles in the chromatograms of 
Figure 2. In each case, the multiplicity count corresponded to a unique combination of 




fluorophore titration experiments. A 200nM 1x concentration of probes in the FAM 
channel allowed for a sufficiently strong signal that minimized cross-channel bleed 
through. 
In any particular experiment, the uncertainty in the cycling data was determined by the 
spread of values in the last five cycles of the particular amplification reaction. This 
uncertainty did not scale with the value of the total signal, which implied that the source 
of uncertainty was instrumental rather than experimental. A 1x fluorphore (200nM) 
baseline was determined by statistical analysis of a set of data on 200nM concentration. 





HIV-1 Poly protease 198mer synthesized from bases 2253 – 2550 
Source HIV-1 Reference Sequence, Los Alamos National Laboratory 
Target sequence 







(3’ to 5’)  
GGAAGCTCTATTAGATACAGGAGCAG 
Reverse Primer 
(3’ to 5’) 
CCAATTATGTTGACAGGTGTAGGTCC 
Probe 1 (3’ to 5’) /56-FAM/TGAGTTTGCCAGGAAGATGGAAACCA/3BHQ_1/ 
Table A.1 HIV-1 Poly Protease Sequence Information 
Sequence Name HIV-1 P17 199mer synthesized from bases 790 – 1186 
Source HIV-1 Reference Sequence, Los Alamos National Laboratory 
Target sequence 







(3’ to 5’)  
CAGCTACAACCATCCCTTCAGACA 
Reverse Primer 
(3’ to 5’) 
TGACCTGATTGCTGTGTCCTGTGT 
Probe 1 (3’ to 5’) /56-FAM/AGCAACCCTCTATTGTGTGCATCAAAGG/3BHQ_1 
Probe 2 (3’ to 5’) /5Cy3/AAAGCACAGCAAGCAGCAGCTGA/3BHQ_2/ 




Sequence Name Malaria ChR7 199mer synthesized from bases 1139138 - 1141223 
Source UCSC Plasmodium falciparum Genome Browser Gateway 
Target sequence 







(3’ to 5’)  
GCCTAACATGGCTATGACGGGTAA 
Reverse Primer 
(3’ to 5’) 
CACCAGACTTGCCCTCCAATTGTT 
Probe 1 (3’ to 5’) /56-FAM/ATTCCGGAGAGGGAGCCTGAGAAATA/3BHQ_1/ 
Probe 2 (3’ to 5’) /56-ROXN/AAGGAAGGCAGCAGGCGCGTAAATTA/3BHQ_2/ 
Table A.3 Malaria ChR7 Sequence Information 
Sequence Name HSV-2 193mer synthesized from HSV-2 genome 
Source EMBL Bank AJ303204 
Target sequence 







(3’ to 5’)  
TCAGCCCATCCTCCTTCGGCAGTAT 
Reverse Primer 
(3’ to 5’) 
CCGAGTTCGATCTGGTACTCGAATGT 
Probe 1 (3’ to 5’) /56-FAM/AAAGACGTGCGGGTCGTACACGTACA/3BHQ_1/ 
Probe 2 (3’ to 5’) /5Cy5/TAAATGCTTCCCTGCTGGTGCCGAT/3IAbRQSp/ 
Table A.4 Herpes Simplex Virus-2 Sequence Information 
Sequence Name Mycobacterium Tuberculosis rpoB 200mer synthesized from 
Mycobacterium tuberculosis rpoB genome 
Source EMBL Bank GQ395623 
Target sequence 







(3’ to 5’)  
GAGTGCAAAGACAAGGACATGACG 
Reverse Primer 
(3’ to 5’) 
AAGTACACACCGGGCGAGC 
Probe 1 (3’ to 5’) /56-FAM/CGCTGTTCGTCACGGCCGAGTTCAT/3BHQ_1/ 
Probe 2 (3’ to 5’) /5Cy3/AGATCAAGAGCCAGACGGTGTTCATG/3BHQ_2/ 
Probe 3 (3’ to 5’) /5Cy5/AAGGGCACCTTCATCATCAACGGCA/3IAbRQSp/ 




Sequence Name Dengue Virus Type 3 200mer synthesized from Dengue Virus Type 3 
genome 
Source GenBank M93130 
Target sequence 







(3’ to 5’)  
ATGCCAACTGTGATTGAGCACT 
Reverse Primer 
(3’ to 5’) 
ACATGTCGGGTTCCTGCTCCTAAA 
Probe 1 (3’ to 5’) /56-
FAM/ACAAAGGAAACATGGAGGAATGCTTGTGA/3BHQ_1/ 
Probe 2 (3’ to 5’) /5Cy3/ACTCTCACGAAACTCCACGCACGAAA/3BHQ_2/ 
Probe 3 (3’ to 5’) /56-ROXN/ACAATGACACACAGGAGACCCACCAT/3BHQ_2/ 
Probe 4 (3’ to 5’) /5Cy5/GGATATCCAATGGTACAGGCAACATCGT/3IAbRQSp/ 
Table A.6 Tuberculosis rpoB Sequence Information 
Reagents Concentration Volume Added 
UltraPure Water - 34µL 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM 2µL 
Primers Concentration Volume Added 
Poly Protease FWD Primer 1µM 2µL 
Poly Protease RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
Poly Protease Probe 1 1µM 2µL 
Table A.7 Experiment 1 Cocktail 
Reagents Concentration Volume Added 
UltraPure Water - 28µL 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
Malaria Template 15nM 2µL 
Herpes Template 17nM 2µL 
TB Template 16nM 2µL 
Dengue Virus Template 17nM 2µL 
Primers Concentration Volume Added 
Poly Protease FWD Primer 1µM 2µL 
Poly Protease RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
Poly Protease Probe 1 1µM 2µL 




Reagents Concentration Volume Added 
UltraPure Water - 32µL 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
Malaria Template 15nM 2µL 
Primers Concentration Volume Added 
Malaria FWD Primer 1µM 2µL 
Malaria RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
Malaria Probe 1 1µM 2µL 
Malaria Probe 2 1µM 2µL 
Table A.9 Experiment 3 Cocktail 
 
Reagents Concentration Volume Added 
UltraPure Water - 26µL 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM 2µL 
Herpes Template 17nM 2µL 
TB Template 16nM 2µL 
Dengue Virus Template 17nM 2µL 
Primers Concentration Volume Added 
Malaria FWD Primer 1µM 2µL 
Malaria RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
Malaria Probe 1 1µM 2µL 
Malaria Probe 2 1µM 2µL 
Table A.10 Experiment 4 Cocktail 
 
Reagents Concentration Volume Added 
UltraPure Water - 32µL 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
Herpes Template 17nM 2µL 
Primers Concentration Volume Added 
Herpes FWD Primer 1µM 2µL 
Herpes RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
Herpes Probe 1 1µM 2µL 
Herpes Probe 2 1µM 2µL 










Reagents Concentration Volume Added 
UltraPure Water - 26µL 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM 2µL 
Malaria Template 15nM 2µL 
TB Template 16nM 2µL 
Dengue Virus Template 17nM 2µL 
Primers Concentration Volume Added 
Herpes FWD Primer 1µM 2µL 
Herpes RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
Herpes Probe 1 1µM 2µL 
Herpes Probe 2 1µM 2µL 
Table A.12 Experiment 6 Cocktail 
 
Reagents Concentration Volume Added 
UltraPure Water - 30µL 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
TB Template 16nM 2µL 
Primers Concentration Volume Added 
TB FWD Primer 1µM 2µL 
TB RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
TB Probe 1 1µM 2µL 
TB Probe 2 1µM 2µL 
TB Probe 3 1µM 2µL 
Table A.13 Experiment 7 Cocktail 
 
Reagents Concentration Volume Added 
UltraPure Water - 30µL 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM 2µL 
Malaria Template 15nM 2µL 
Herpes Template 17nM 2µL 
Dengue Virus Template 17nM 2µL 
Primers Concentration Volume Added 
TB FWD Primer 1µM 2µL 
TB RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
TB Probe 1 1µM 2µL 
TB Probe 2 1µM 2µL 
TB Probe 3 1µM 2µL 





Reagents Concentration Volume Added 
UltraPure Water - 28µL 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
Dengue Virus Template 17nM 2µL 
Primers Concentration Volume Added 
Dengue Virus FWD Primer 1µM 2µL 
Dengue Virus RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
Dengue Virus Probe 1 1µM 2µL 
Dengue Virus Probe 2 1µM 2µL 
Dengue Virus Probe 3 1µM 2µL 
Dengue Virus Probe 4 1µM 2µL 
Table A.15 Experiment 9 Cocktail 
 
Reagents Concentration Volume Added 
UltraPure Water - 22µL 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM 2µL 
Malaria Template 15nM 2µL 
Herpes Template 17nM 2µL 
TB Template 16nM 2µL 
Primers Concentration Volume Added 
Dengue Virus FWD Primer 1µM 2µL 
Dengue Virus RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
Dengue Virus Probe 1 1µM 2µL 
Dengue Virus Probe 2 1µM 2µL 
Dengue Virus Probe 3 1µM 2µL 
Dengue Virus Probe 4 1µM 2µL 



















Reagents Concentration Volume Added 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM 2µL 
Malaria Template 15nM 2µL 
Herpes Template 17nM 2µL 
Dengue Virus Template 17nM 2µL 
Primers Concentration Volume Added 
Poly Protease FWD Primer 1µM 2µL 
Poly Protease RVS Primer 1µM 2µL 
Malaria FWD Primer 1µM 2µL 
Malaria RVS Primer 1µM 2µL 
Herpes FWD Primer 1µM 2µL 
Herpes RVS Primer 1µM 2µL 
Dengue Virus FWD Primer 1µM 2µL 
Dengue Virus RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
Poly Protease Probe 1 1µM 2µL 
Malaria Probe 1 1µM 2µL 
Malaria Probe 2 1µM 2µL 
Herpes Probe 1 1µM 2µL 
Herpes Probe 2 1µM 2µL 
Dengue Virus Probe 1 1µM 2µL 
Dengue Virus Probe 2 1µM 2µL 
Dengue Virus Probe 3 1µM 2µL 
Dengue Virus Probe 4 1µM 2µL 
























Reagents Concentration Volume Added 
UltraPure Water - 2µL 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM 2µL 
Malaria Template 15nM 2µL 
Herpes Template 17nM 2µL 
TB Template 16nM 2µL 
Primers Concentration Volume Added 
Poly Protease FWD Primer 1µM 2µL 
Poly Protease RVS Primer 1µM 2µL 
Malaria FWD Primer 1µM 2µL 
Malaria RVS Primer 1µM 2µL 
Herpes FWD Primer 1µM 2µL 
Herpes RVS Primer 1µM 2µL 
TB FWD Primer 1µM 2µL 
TB RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
Poly Protease Probe 1 1µM 2µL 
Malaria Probe 1 1µM 2µL 
Malaria Probe 2 1µM 2µL 
Herpes Probe 1 1µM 2µL 
Herpes Probe 2 1µM 2µL 
TB Probe 1 1µM 2µL 
TB Probe 2 1µM 2µL 
TB Probe 3 1µM 2µL 
























Reagents Concentration Volume Added 
UltraPure Water - 12µL 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM 2µL 
Herpes Template 17nM 2µL 
TB Template 16nM 2µL 
Primers Concentration Volume Added 
Poly Protease FWD Primer 1µM 2µL 
Poly Protease RVS Primer 1µM 2µL 
Herpes FWD Primer 1µM 2µL 
Herpes RVS Primer 1µM 2µL 
TB FWD Primer 1µM 2µL 
TB RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
Poly Protease Probe 1 1µM 2µL 
Herpes Probe 1 1µM 2µL 
Herpes Probe 2 1µM 2µL 
TB Probe 1 1µM 2µL 
TB Probe 2 1µM 2µL 
TB Probe 3 1µM 2µL 
Table A.19 Experiment 13 Cocktail 
 
Reagents Concentration Volume Added 
UltraPure Water - 10µL 
Taq 5x Master Mix - 42µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM 2µL 
Malaria Template 15nM 2µL 
Dengue Virus Template 17nM 2µL 
Primers Concentration Volume Added 
Poly Protease FWD Primer 1µM 2µL 
Poly Protease RVS Primer 1µM 2µL 
Malaria FWD Primer 1µM 2µL 
Malaria RVS Primer 1µM 2µL 
Dengue Virus FWD Primer 1µM 2µL 
Dengue Virus RVS Primer 1µM 2µL 
Probes Concentration Volume Added 
Poly Protease Probe 1 1µM 2µL 
Malaria Probe 1 1µM 2µL 
Malaria Probe 2 1µM 2µL 
Dengue Virus Probe 1 1µM 2µL 
Dengue Virus Probe 2 1µM 2µL 
Dengue Virus Probe 3 1µM 2µL 
Dengue Virus Probe 4 1µM 2µL 





Reagents Concentration Volume Added 
UltraPure Water - 50µL 
Taq 5x Master Mix - 25µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM 4µL 
P17 Template 15nM 4µL 
Dengue Virus Template 17nM 4µL 
Primers Concentration Volume Added 
Poly Protease FWD Primer 1µM 4µL 
Poly Protease RVS Primer 1µM 4µL 
P17 FWD Primer 1µM 4µL 
P17 RVS Primer 1µM 4µL 
Dengue Virus FWD Primer 1µM 4µL 
Dengue Virus RVS Primer 1µM 4µL 
Probes Concentration Volume Added 
Poly Protease Probe 1 800nM 4µL 
P17 Probe 1 400nM 4µL 
Dengue Virus Probe 1 200nM 4µL 
Table A.21 Binary FAM Experiment 1 Cocktail 
 
Reagents Concentration Volume Added 
UltraPure Water - 54µL 
Taq 5x Master Mix - 25µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM - 
P17 Template 15nM 4µL 
Dengue Virus Template 17nM 4µL 
Primers Concentration Volume Added 
Poly Protease FWD Primer 1µM 4µL 
Poly Protease RVS Primer 1µM 4µL 
P17 FWD Primer 1µM 4µL 
P17 RVS Primer 1µM 4µL 
Dengue Virus FWD Primer 1µM 4µL 
Dengue Virus RVS Primer 1µM 4µL 
Probes Concentration Volume Added 
Poly Protease Probe 1 800nM 4µL 
P17 Probe 1 400nM 4µL 
Dengue Virus Probe 1 200nM 4µL 












Reagents Concentration Volume Added 
UltraPure Water - 54µL 
Taq 5x Master Mix - 25µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM 4µL 
P17 Template 15nM - 
Dengue Virus Template 17nM 4µL 
Primers Concentration Volume Added 
Poly Protease FWD Primer 1µM 4µL 
Poly Protease RVS Primer 1µM 4µL 
P17 FWD Primer 1µM 4µL 
P17 RVS Primer 1µM 4µL 
Dengue Virus FWD Primer 1µM 4µL 
Dengue Virus RVS Primer 1µM 4µL 
Probes Concentration Volume Added 
Poly Protease Probe 1 800nM 4µL 
P17 Probe 1 400nM 4µL 
Dengue Virus Probe 1 200nM 4µL 
Table A.23 Binary FAM Experiment 3 Cocktail 
 
Reagents Concentration Volume Added 
UltraPure Water - 54µL 
Taq 5x Master Mix - 25µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM 4µL 
P17 Template 15nM 4µL 
Dengue Virus Template 17nM - 
Primers Concentration Volume Added 
Poly Protease FWD Primer 1µM 4µL 
Poly Protease RVS Primer 1µM 4µL 
P17 FWD Primer 1µM 4µL 
P17 RVS Primer 1µM 4µL 
Dengue Virus FWD Primer 1µM 4µL 
Dengue Virus RVS Primer 1µM 4µL 
Probes Concentration Volume Added 
Poly Protease Probe 1 800nM 4µL 
P17 Probe 1 400nM 4µL 
Dengue Virus Probe 1 200nM 4µL 












Reagents Concentration Volume Added 
UltraPure Water - 58µL 
Taq 5x Master Mix - 25µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM - 
P17 Template 15nM - 
Dengue Virus Template 17nM 4µL 
Primers Concentration Volume Added 
Poly Protease FWD Primer 1µM 4µL 
Poly Protease RVS Primer 1µM 4µL 
P17 FWD Primer 1µM 4µL 
P17 RVS Primer 1µM 4µL 
Dengue Virus FWD Primer 1µM 4µL 
Dengue Virus RVS Primer 1µM 4µL 
Probes Concentration Volume Added 
Poly Protease Probe 1 800nM 4µL 
P17 Probe 1 400nM 4µL 
Dengue Virus Probe 1 200nM 4µL 
Table A.25 Binary FAM Experiment 5 Cocktail 
 
Reagents Concentration Volume Added 
UltraPure Water - 58µL 
Taq 5x Master Mix - 25µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM - 
P17 Template 15nM 4µL 
Dengue Virus Template 17nM - 
Primers Concentration Volume Added 
Poly Protease FWD Primer 1µM 4µL 
Poly Protease RVS Primer 1µM 4µL 
P17 FWD Primer 1µM 4µL 
P17 RVS Primer 1µM 4µL 
Dengue Virus FWD Primer 1µM 4µL 
Dengue Virus RVS Primer 1µM 4µL 
Probes Concentration Volume Added 
Poly Protease Probe 1 800nM 4µL 
P17 Probe 1 400nM 4µL 
Dengue Virus Probe 1 200nM 4µL 












Reagents Concentration Volume Added 
UltraPure Water - 58µL 
Taq 5x Master Mix - 25µL 
Templates Concentration Volume Added 
Poly Protease Template 17nM 4µL 
P17 Template 15nM - 
Dengue Virus Template 17nM - 
Primers Concentration Volume Added 
Poly Protease FWD Primer 1µM 4µL 
Poly Protease RVS Primer 1µM 4µL 
P17 FWD Primer 1µM 4µL 
P17 RVS Primer 1µM 4µL 
Dengue Virus FWD Primer 1µM 4µL 
Dengue Virus RVS Primer 1µM 4µL 
Probes Concentration Volume Added 
Poly Protease Probe 1 800nM 4µL 
P17 Probe 1 400nM 4µL 
Dengue Virus Probe 1 200nM 4µL 









A p p e n d i x  B  
SEQUENCE INFORMATION 
Sequence 
Information HIV-1 40mer, 60mer, and 80mer 
Source HIV-1 Reference Sequence, Los Alamos National Laboratory 
40Mer Template 5'- GGA AGC TCT ATT AGA TAC AGA CAC CTG TCA ACA TAA TTG G -3' 
60Mer Template 5'- GGA AGC TCT ATT AGA TAC AGA TGA TAC AGT ATT AGA AGA AAC ACC TGT CAA CAT AAT TGG -3' 
80Mer Template 
5'- GGA AGC TCT ATT AGA TAC AGA TGA TAC AGT ATT AGA 
AGA AAT GAG TTT GCC AGG AAG ATG ACA CCT GTC AAC 
ATA ATT GG -3' 
FWD Primer 5'- /5Cy3/GG AAG CTC TAT TAG ATA CAG -3' 
RWD Primer 5'- /5IABkFQ/CC AAT TAT GTT GAC AGG TGT -3' 
Table 8.1 HIV-1 Poly Protease Sequence Information 
 
Sequence 
Information Influenza A 
Source GenBank Accession #M23976.1 Influenza A 
85Mer Template 
5' GTA GGG ATA GAC CCT TTC AAA CTG CTT CAA AAC AGC 
CAA GTA TAC AGC CTA ATC AGA CCG AAT GAG AAT CCA 
GCA CAC AAG AGT C 3' 
FWD Primer 5' GTA GGG ATA GAC CCT TTC AAA CTG 3' 
RWD Primer 5' GAC TCT TGT GTG CTG GAT TCT C 3' 
TaqMan Probe 5' /56 FAM/AG CCA AGT ATA CAG CCT AAT CAG ACC GA/3BHQ_1/ 3' 
FWD qPrimer 5' /5Cy3/GT AGG GAT AGA CCC TTT CAA ACT G 3' 
RWD qPrimer 5' /5IABkFQ/GA CTC TTG TGT GCT GGA TTC TC 3' 
FWD Mistake 
qPrimer 5' /5Cy3/GT AGG GAG AGA CCC TTT CAA ACT G 3' 













Information Influenza B 
Source GenBank Accession # AB036876 Influenza B 
81Mer Template 
5' GTG CTT CCC ATA AGC ATT TAC GCC AAA ATA CCT CAA 
CTA GGG TTC AAC GTT GAA GAG TAC TCT ATG GTT GGG 
TAT GAA GCC 3' 
FWD Primer 5' GTG CTT CCC ATA AGC ATT TAC G 3' 
RWD Primer 5' GGC TTC ATA CCC AAC CAT AGA G 3' 
TaqMan Probe 5' /56 FAM/CC TCA ACT AGG GTT CAA CGT TGA AGA GT/3BHQ_1/ 3' 
FWD qPrimer 5' /5Cy3/GT GCT TCC CAT AAG CAT TTA CG 3' 
RWD qPrimer 5' /5IABkFQ/GG CTT CAT ACC CAA CCA TAG AG 3' 
Table 8.3 Influenza type B sequence information 
 
Sequence 
Information Respiratory syncytial virus type A 
Source GenBank Accession # |JX627336.1|:5726-7450 Human respiratory syncytial virus strain RSVA/GN435/11, complete genome 
85Mer Template 
5' GTT GGA AAC TAC ACA CAT CTC CTC TAT GTA CAA CCA 
ACA CAA AGG AAG GAT CCA ACA TCT GCT TAA CAA GAA 
CCG ACA GAG GAT G 3' 
FWD Primer 5' GTT GGA AAC TAC ACA CAT CTC CTC 3' 
RWD Primer 5' CAT CCT CTG TCG GTT CTT GTT AAG 3' 
TaqMan Probe 5' /56 FAM/CC AAC ACA AAG GAA GGA TCC AAC ATC TG/3BHQ_1/ 3' 
FWD qPrimer 5' /5Cy3/GT TGG AAA CTA CAC ACA TCT CCT C 3' 
RWD qPrimer 5' /5IABkFQ/CA TCC TCT GTC GGT TCT TGT TAA G 3' 
Table 8.4 Respiratory syncytial virus type A sequence information 
 
Sequence 
Information Respiratory syncytial virus type B 
Source GenBank Accession # JX682822.1 
81Mer Template 
5' CCT CAC CTC AAG TCA GAA CAT AAC TGA GGA GTT TTA 
CCA ATC GAC ATG TAG TGC AGT TAG CAG AGG TTA CTT 
GAG TGC TTT 3' 
FWD Primer 5' CCT CAC CTC AAG TCA GAA CAT AAC 3' 
RWD Primer 5' AAA GCA CTC AAG TAA CCT CTG C 3' 
TaqMan Probe 5' /56 FAM/AC CAA TCG ACA TGT AGT GCA GT/3BHQ_1/ 3' 
FWD qPrimer 5' /5Cy3/CC TCA CCT CAA GTC AGA ACA TAA C 3' 
RWD qPrimer 5' /5IABkFQ/AA AGC ACT CAA GTA ACC TCT GC 3' 








Information Human rhinovirus 
Source GenBank Accession # AF108174.1 
81Mer Template 
5' ACA ATG GAC AAG GTG TGA AGA GCC CCG TGT GCT CGC 
TTT GAG TCC TCC GGC CCC TGA ATG TGG CTA ACC TTA ACC 
CTG CAG CTA G 3' 
FWD Primer 5' ACA ATG GAC AAG GTG TGA AGA G 3' 
RWD Primer 5' CTA GCT GCA GGG TTA AGG TTA G 3' 
TaqMan Probe 5' /56 FAM/TG TGC TCG CTT TGA GTC CTC CG/3BHQ_1/ 3' 
FWD qPrimer 5' /5Cy3/AC AAT GGA CAA GGT GTG AAG AG 3' 
RWD qPrimer 5' /5IABkFQ/CT AGC TGC AGG GTT AAG GTT AG 3' 
Table 8.6 Human rhinovirus sequence information 
 
Sequence 
Information Human metapneumovirus 
Source GenBank Accession # |AF371337.2|:3052-4671 Human metapneumovirus isolate 00-1, complete genome) 
88Mer Template 
5' GAG AGC ATT GAG AAC AGT CAG GCC TTG GTG GAT CAA 
TCA AAC AGA ATC CTA AGC AGT GCA GAG AAA GGA AAC 
ACT GGC TTC ATC ATT G 3' 
FWD Primer 5' GAG AGC ATT GAG AAC AGT CAG G 3' 
RWD Primer 5' CAA TGA TGA AGC CAG TGT TTC C 3' 
TaqMan Probe 5' /56 FAM/AC AGA ATC CTA AGC AGT GCA GAG A/3BHQ_1/ 3' 
FWD qPrimer 5' /5Cy3/GA GAG CAT TGA GAA CAG TCA GG 3' 
RWD qPrimer 5' /5IABkFQ/CA ATG ATG AAG CCA GTG TTT CC 3' 
Table 8.7 Human metapneumovirus sequence information 
 
 
